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 The research addressed in this thesis focuses on monitoring and characterization 
of pharmaceutical compounds by laser backscattering.  In particular, this study covers 
two topics:  (1) the determination of naproxen sodium solubility in water, and its phase 
transition; and (2) comparisons of batch and laminar flow tubular crystallizers for the 
production of paracetamol (acetaminophen) and D-mannitol.   
 Using a Lasentec® Focused Beam Reflectance Measurement (FBRM) device, the 
solubility of naproxen sodium in aqueous solutions was determined over a temperature 
range from 15.2 to 39.7 °C.  With the determination of the solubilities of two 
pseudopolymorphs, anhydrous and dihydrated naproxen sodium, the phase transition 
point between these two forms of the pharmaceutical compound was determined to occur 
at 30.3 °C.  Enthalpy of solution and metastable zone widths were also determined for the 
experimental conditions. 
 Crystallizations of paracetamol and D-mannitol were performed in a batch 
crystallizer and in a laminar flow tubular crystallizer (LFTC) system.  In the latter 
system, supersaturation was generated rapidly in the solution being transported through a 
temperature-controlled tube and recovered in a batch vessel where product crystals were 
grown to equilibration.  Because of the rapid rate at which supersaturation was generated 
in the LFTC, the resulting crystals were of smaller mean size than those obtained from 
batch crystallizations.  The total time required for crystallization was significantly less 
with the LFTC than with the batch unit.  Additionally, the rapid cooling in the LFTC led 





 The advent of novel technologies has facilitated online process monitoring in 
many areas of chemical process engineering.  One of these technologies, the Lasentec® 
Focused Beam Reflectance Measurement (FBRM) device, utilizes laser backscattering to 
monitor chord length distributions of particles in fluid systems.  This instrument allows in 
situ monitoring of characteristics of crystal or particle size, without sampling, in an 
immediate and reliable fashion.  Such advantages prove useful in the field of 
crystallization where the understanding of process dynamics is essential.  Two separate 
projects are described in this thesis.  In both of them the FBRM was an indispensable 
tool.   
Motivated by the work of Kim1, 2 on the crystallization and characterization of 
naproxen sodium, the current work presents the solubility diagram of this material in 
aqueous solutions for a temperature range of 15.2 to 39.7 °C.  The use of the FBRM did 
not only help in accomplishing this, but also in detecting the transition temperature 
between the dihydrate and the anhydrous form of this material.   
 Also, a laminar-flow tubular crystallizer (LFTC) is presented as an alternative to 
common batch crystallizers.  Work by Brenek et al.3 with a similar crystallizer served as 
a motivation for this study.  In their work, the researchers found that crystals of a 
specific, but unidentified, pharmaceutical compound obtained from such a system 
differed substantially in size and morphology from those obtained from batch 
crystallization.  
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In the present project, the FBRM was used to analyze the product crystals from 
the LFTC. It was found that this system is capable of producing crystals of smaller mean 
size than in typical batch processes, and under the right conditions, the run times are 
significantly reduced.  It was also found that the LFTC simultaneously produced varying 
amounts of Forms I and II of paracetamol.  The FBRM also proved useful in the 
estimation of nucleation rates for the studied systems. 
The outline of this thesis is as follows: Chapter 2 provides essential background 
related to the projects.  Topics such as crystallization, metastable zones, polymorphism, 
FBRM, and cooling crystallizer design are discussed.  Chapters 3 and 4 provide the key 
aspects of the research conducted in this study; specifically, Chapter 3 is  Determination 
of Naproxen Sodium Solubility and Related Properties in Water using a Lasentec FBRM, 
and Chapter 4 is Process Monitoring and Characterization of Paracetamol and D-
mannitol Crystallizations: Batch and Laminar-Flow Tubular Crystallizers.  Experimental 






 Background information about crystallization, metastable zones and 
polymorphism considered relevant for this project are discussed in this chapter.  A brief 
introduction to the Lasentec® FBRM equipment, use throughout this research, is 
included.  A section concerning cooling crystallizers is also presented. 
 
2.1  Crystallization 
 Crystallization processes are common in a wide variety of industries.  These 
industries rely on crystallization for the production, separation and/or purification of 
chemicals.  The driving force behind this process is the supersaturation, S, which relates 
the solute concentration of the system, Ci, to the concentration at equilibrium, Ci*, 




CS =                                                            (2.1) 
Sometimes this driving force is expressed in terms of relative supersaturation σ, or 








iiσ                                                (2.2) 
Following or accompanying supersaturation is the nucleation and growth of crystals.  
Nucleation phenomena can occur from a clear solution (primary nucleation), or be 
induced by the presence of other crystals (secondary nucleation).  Furthermore, primary 
nucleation can be classified as homogeneous (occurring spontaneously), or as 
heterogeneous, where nucleation is induced by foreign particles.4  The interesting 
subjects of supersaturation, nucleation and growth have been discussed in much detail in 
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textbooks, such as those by Nývlt, et al.5 and Kashchiev6, practically devoted in their 
entirety to these phenomena. 
 Although different types of crystallization mechanisms exist, such as cooling and 
evaporation, and crystallization from melts, vapors or solutions, the following discussion 
will focus mainly on cooling crystallization from solutions, as it is directly applicable to 
this research. 
 
2.2 Metastable Zone 
 Attaining supersaturation in a system would lead to its metastability, and not 
necessarily to the immediate nucleation of crystals.  Figure 2-1 shows a schematic of 
solubility and metastable zone.  In cooling crystallization, when a homogeneous solution 
in point a passes the solubility curve to point b, it is considered to be supersaturated and 
within the metastable zone.  If the solution is kept at this temperature, eventually, 
nucleation and growth will occur.  The closer the solution is to the metastable limit, the 
faster crystallization takes place.  Now, if upon very fast cooling, the solution at point a is 
taken to point c, past its metastable limit, an uncontrolled crystallization would occur, 
promoting the formation of fines.7  In many cases fines are undesired in the final 
product,8, 9 as they might present filtration problems,8 and affect dissolution and 
encapsulation properties in the case of pharmaceuticals.  Usually a constant 
supersaturation that would allow a narrower size distribution is desired (Fig. 2-2); often 















Figure 2-1.  Solubility and metastable limit diagram.  At a the solute is fully dissolved in solution; at b the 



















Metastable limits can be found experimentally by identifying the temperature at 
which nucleation starts for a solution of known concentration cooled at a constant rate.  
Nývlt et al.5 also describe an isothermal method for measuring metastable zone width 
based on induction period.  The width of the metastable zone, or the maximum allowable 
undercooling, would be the difference between the saturation and nucleation 
temperatures.  The saturation temperatures forming the solubility curve for the system 
can be determined by analytic or synthetic methods.10  Examples of these methods can be 
found in the literature.4, 5, 10  The use of on-line measurement tools has benefited the 
process of determining both the metastable zone width and solubility by providing 
reliable and easy-to-use methods for these purposes.11-14  
It is important to notice, as it will be shown in chapter 3 and 4, that generally the 
metastable zone is widened with increasing cooling rates and lowering concentrations.  
Many researchers have shown experimental data proving this behavior.  In general, the 
critical supersaturation ratio is proportional to the exponential of T -3/2.  Which means that 
with increasing temperatures, the critical supersaturation required for nucleation is 
reduced, henceforth reducing the metastable limit.  A well developed model of this is 
found in Kashchiev’s monograph.6 
The rate at which supersaturation is generated also affects the width of the 
metastable zone; henceforth the cooling rate affects the metastable limit.  In general, the 
cooling rate is proportional to the metastable zone width to the power of the nucleation 
order.  It follows then that for a constant nucleation order, the increasing cooling rates 
will render greater metastable zone widths.  A summary of relations regarding the 
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dependence of the metastable zone width on cooling rates can be found in Nývlt et al.5 
along with other elements that also affect the metastable limit.  
 
2.3  Polymorphism 
 Many chemical compounds exhibit polymorphism; their molecules are able to 
exist in different lattice arrangements.  A polymorph of a particular compound would 
have different characteristics than another polymorph.  This affects properties such as 
solubility and morphology, and in the case of pharmaceuticals it would affect 
compression and filtration properties, dissolution rate and bioavailability.  A similar 
phenomenon that could also affect these properties is pseudopolymorphism.  In this case, 
crystals of the same chemical composition incorporate solvent molecules within their 
lattice sites with a defined stoichiometry.15  These crystals are known as solvates, and 
when the solvent is water they are known as hydrates.  McCrone16 also mentions other 
examples of pseudopolymorphism; yet the utilization of the term for these cases has 
fallen into disuse.17 
Morris18 points out the differences and similarities between polymorphs and 
hydrates, with a more detailed approach in characterizing the structural aspects of 
hydrates.  He adjudges the differences between polymorphs and hydrates on the basis of 
crystal structure; a hydrate’s structure is a function of the water vapor pressure above the 
solid, while for a polymorph its structure is only affected by changes in water vapor 
pressure if water sorption allows molecular motion, which would permit a solution 
mediated transformation. 
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 In polymorphism (and pseudopolymorphism) we can identify metastable and 
stable forms, also known as kinetically stable and thermodynamically stable 
modifications, respectively.  For a given temperature range, the stable form will be the 
one with lower solubility.  Metastable forms are not necessarily restricted to one; in fact 
there could be multiple metastable forms of a crystal molecule, with varying 
metastablility according to the temperature range.  As we will see, a stable form can be 
metastable at a different section of its phase diagram. 
 Polymorphic systems can be considered monotropic or enantiotropic.  In a 
monotropic system (Fig. 2-3) the stable polymorph will retain its lower solubility 
throughout the phase diagram when compared to the metastable form.  Monotropic 
transformations of polymorphs are considered irreversible.4  Enantiotropic systems (Fig. 
2-4) though, exhibit transition points at which the considered metastable form at lower 
temperatures would become stable at higher temperatures, rendering the previous stable 
form into a metastable one.  Because of the presence of a transition temperature between 
forms, enantiotropic transformations are considered reversible.4  Caution is advised were 
in doubt of the behavior of the system under study.  While one would believe that a 
system exhibits monotropic behavior, it could in fact be an enantiotropic system at a 
different temperature range. 
 Morris18 indicates that it is often desired to use the thermodynamically stable form 
for formulation development of pharmaceutical drugs, mainly due to the lower risk of 
phase transition.  In some instances though, a metastable form is desired due to 
performance or regulatory issues, or in cases in which the stable form is not obtained 
directly.  Guillory19 states that the metastable form may be preferred when absorption of 
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the drug is dependent of the dissolution rate, and that it is often this form the one used in 
capsules or tablets.  On the other hand, since the stable form is less prone to 
transformation, it may be the only form considered for suspensions. 
 Researchers have developed different techniques in order to produce a desired 
polymorph.  In some cases fast cooling will produce the kinetically stable polymorph, 
while slow cooling would produce the thermodynamically stable one; this follows the 
discussion of metastable zones, at slower cooling rates, the metastable limit will be closer 
to the solubility of the system, particularly to the most stable one.  In other cases, like 
with glycine20, sulfamerazine21, and D-mannitol22, crystallization with different solvents 
enables the formation of different forms.   Seeding a supersaturated solution with the 
desired form is also a normal practice.23  In certain cases inhibiting agents are added to 
solutions to avoid the growth of an undesired form.24  It has been reported for the case of 
glycine that polarized light affects the formation of polymorphs.25  Novel crystallizer 
design is also an alternative to control polymorphism.3, 26, 27  
It is important, especially for pharmaceuticals, to consider carefully the choice of 
polymorph for the final product.  A metastable form can be acquired and retained in 
dosage form, yet it could “relax” to a more stable phase, altering its properties.  
Furthermore, the transformation from metastable to a more thermodynamically stable 
form can occur in any downstream process, such as aqueous granulation, milling, film 
coating or tablet compression.18  Brittain and Fiese28 also mention that the substantial 
amount of energy used in milling processes can also incur in the transformation of the 














Figure 2-3.  Solubility diagram for monotropic polymorphism.  Form I is considered the 















Figure 2-4.  Solubility diagram for enantiotropic polymorphism.  Form I is the stable form below the 
transition temperature, while Form II is the metastable one.  Above the transition point, Form I becomes 
metastable, while Form II becomes stable. 
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 From this discussion it is obvious that knowledge of the polymorphic forms and 
properties of the material under production is highly advisable for those who manufacture 
the product.  Chemburkar et al.29 narrate the story of ritonavir, a protease inhibitor 
developed by Abbott Laboratories, whose thermodynamically stable polymorph was not 
readily discovered.  Two years after production of the drug started, some lots failed 
dissolution specifications.  A less soluble, more stable polymorph was discovered in these 
lots.  Shortly after, many lots in different lines were experiencing the same problems.  
Abbott was put into “a market crisis”, with rapidly depleting supplies.  The whole 
production process had to be redesign to acquire the original, kinetically stable form. 
 Glaxo experienced its share of polymorphism issues with is drug Zantac 
(ranitidine hydrochloride).30, 31  Two years after the original form was patented, a new 
more stable one was found, which later became the active ingredient in Zantac.  When 
the patent for the first form expired, generic companies wanted to produce it.  But the 
question was raised, whether the generic companies were able to produce it without 
concomitantly producing the second form.  This and other cases that underwent litigation 
due to polymorphism and patent protection are summarized elsewhere.31 
 Due to cases like these is probably why Bernstein32 indicates that “most examples 
of polymorphism are still discovered through serendipity”.  Or also the reason why many 
authors17, 30, 32, 33 quote McCrone’s16 statement that in his opinion “every compound has 
different polymorphic forms and that, in general, the number of forms known for a given 
compound is proportional to the time and money spent in research on that compound”. 
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 The current level of computer simulations cannot predict accurately the right 
polymorphs that are going to form for a particular material, henceforth, to selectively 
produce a specific polymorph is not a straightforward task.34 
  
The Ostwald rule of stages35 is often mentioned to explain the polymorphism 
phenomena in crystallization.  It is used to show how a crystallized compound can 
change from a metastable form to a more stable one, especially through solvent mediated 
transformation.  In this process, metastable crystals redisolve into solution while then 
more stable crystals nucleate.  In essence, the system crystallizes loosing the minimum 
amount of free energy possible, from one phase to the next.  Nonetheless, the rule has 
numerous exceptions.   
The most appropriate way to explain polymorphism behavior in crystallization 
processes is to carefully analyze phase diagrams with metastable limits data.  
Enantiotropic systems also show a better variety of instructional possibilities according to 
the supersaturation / crystallization path chosen.  For this, the reader is directed to the 
article by Threlfall33 where the crystallization of polymorphs with enantiotropic diagrams 
is discussed in much detail.  In this article, Threlfall tries to dismiss oversimplifications 
or misjudgments often committed while analyzing the crystallization of polymorphs.  
In general, it is a good advice to know firsthand how far apart are the polymorphic 
forms in the phase diagram if one wishes to crystallize the metastable form.9 
Furthermore, the crystallization techniques get to be more “complicated” if not only a 
specific polymorph is desired, but also a particular crystal size distribution.15  For this 
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reason the control of polymorphism and crystal size can be considered paradigms of 
crystallization.   
 
2.4  Lasentec® Focused Beam Reflectance Measurement  
 On-line techniques have been used in the laboratories for years to facilitate the 
analysis of experiments.  These process analytical technologies (PAT’s) have also 
penetrated industry.  In some, like in pharmaceuticals where there is a strict regulatory 
environment, these tools have slowly moved into the manufacturing sector.  Recognizing 
this, the U.S. Food and Drug Administration (FDA) announced in August 2002 a revision 
of the current Good Manufacturing Practices (cGMP’s).36  In 2003, the FDA published its 
Guidance for Industry: PAT – A Framework for Innovative Pharmaceutical 
Manufacturing and Quality Assurance,37 as a first step in improving the incursion of 
PAT’s in these areas. 
 One example of a PAT is the Lasentec® Focused Beam Reflectance Measurement 
(FBRM®) instrument, which was used extensively during the present work.  The FBRM 
provides the on-line and in-situ ability of measuring the chord length distribution (CLD) 
of a particulate system through laser backscattering.  A highly focused laser beam in the 
probe (Fig. 2-5a), rotating at a fixed velocity, scans the particles in a small region in front 
of the probe’s sapphire window.  When the beam hits a particle, the optical sensors in the 
probe pick up the backscattering, and the data is analyzed by the system.  The chord 
length (Fig. 2-5b), or the distance between two edges in a particle, is then calculated as 
the product of the beam speed and the time of the corresponding backscattering signal.   
The thousands of chord lengths per second that can be acquired by the instrument are 
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organized in channels and expressed as distributions.  The statistical data can be observed 
on-line and/or saved for later analysis.  A more detailed description of the FBRM can be 
found elsewhere.38, 39 
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Figure 2-5.  (a) Schematic of FBRM probe and (b) possible chord lengths of a particle. 
 
 It is important to notice that by no means CLD is the same as particle size 
distribution (PSD).  Taking into account the statistical meaning of CLD researchers have 
developed models40-43 to convert and relate CLD’s to PSD’s.   
The importance of acquiring a desired PSD relies on different factors, like product 
dissolution rate or packaging reasons.  In the case of pharmaceuticals a narrow PSD is 
desired usually to allow a more uniform dissolution rate of the drug.  When a smaller 
mean size is desired, downstream processes, such as milling, are used to reduce it.  This 
not only adds to the inconvenience of time and money spent on the process, but also on 




2.5 Cooling Crystallizers 
Although a simple search in crystallization textbooks shows a great variety of 
cooling crystallizers, such as agitated tank, cooling disc, rotary, scraped-surface,4 twin, 
Wulff-Bock, Swenson-Walker,4, 10 Oslo,4, 10, 44 direct contact,4, 44 and spray crystallizers44 
among others, much of the attention is focused on batch and mixed suspension, mixed 
product removal (MSMPR) crystallizers. 
 Batch crystallizers are widely used in industry.  These crystallizers are flexible, 
simple, require less capital investment and generally less process development than 
continuous units.7, 45  Their versatility allows them to be used as reactors, crystallizers, 
mixers and blenders; thus the emphasis in design tends more on the mode of operation.7  
Their relative simplicity allows for non-stringent qualification of personnel.10  The use of 
batch crystallizers in the crystallization field is not limited to cooling crystallization, but 
they are also used in evaporative, drowning out and reaction crystallization.  
Supersaturation control is essential to the operation of batch crystallizers.  This control 
depends on the operating policy based on batch time, rate at which supersaturation is 
generated, possible addition of seed crystals, and agitation.7 Because batch crystallizers 
do not operate under steady state conditions, the modeling of crystal size distribution is 
more complex than that of continuous crystallizers, due to its dependency on both crystal 
size and time.46  The developed models based on population balances can be found 
elsewhere,5, 45-47 and is mainly attributed to the work of Randolph and Larson46.  Semi-
batch crystallizers are probably not as often mentioned in literature as batch crystallizers, 
but like batch crystallizers, they also offer a relative operational simplicity.  A discussion 
of semi-batch crystallizers can be found in Tavare’s monograph45. 
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 MSMPR crystallizers are often discussed in terms of their simplicity of modeling, 
rather than operation.  MSMPR’s are the crystallizer equivalent of continuous stirred tank 
reactors (CSTR’s).  The analysis for particle population assumes among other things that 
the crystallizer operates continuously and under steady state conditions.7   Detailed 
analysis for crystal size distribution modeling can be found in the literature.5, 45-47  
Another type of crystallizer that is not as often described in literature is the 
tubular crystallizer.  Crystal size distribution analyses capitalize on plug-flow conditions 
for narrow distributions.  Population balance models can be found in the literature.46, 48  
Examples of tubular crystallizers can be found in the sugar industry48 where tower 
crystallizers are used.  But a general search on tubular crystallizers would point to foreign 
publications49-54 for more fundamental knowledge about their operation as well as foreign 
patents55-59 that propose different applications.  Most of these foreign works are not 
readily available to the scientific community.   
A laminar-flow tubular crystallizer with countercurrent cooling fluid was used in 
the present work.  Its design is based on that of Brenek et al.3  Fundamental knowledge 
was pursued by comparison of its operation to a batch crystallizer.  Heat transfer analysis 







DETERMINATION OF NAPROXEN SODIUM SOLUBILITY AND RELATED 
PROPERTIES IN WATER USING A LASENTEC FBRM 
 
 Using a Lasentec FBRM, the solubility of naproxen sodium in water was 
determined over a temperature range from 15.2 to 39.7 °C.  Van’t Hoff plots of the data 
showed a transition temperature between the enantiotropic pseudopolymorphs at 29.8 °C.  
A multiple regression analysis of the same data estimated the transition point to be     
30.3 °C.  Powder X-ray diffraction showed that the anhydrous form of naproxen sodium 
is stable above the transition point, while below it, the dihydrate is the stable form.  
Enthalpy of solution as a linear function of temperature was estimated from the multiple 
regression analysis for both forms.  Metastable zone widths and relative supersaturation 
at nucleation were determined for four different cooling rates (0.15, 0.20, 0.30 and 0.40 
°C/min). 
 
3.1  Introduction 
3.1.1  Naproxen Sodium Solubility 
Naproxen sodium is a non-steroidal anti-inflammatory agent commonly found as 
the active ingredient in over-the-counter drugs.  Although many characterization studies 
have been published, for example in drug absorption60-62 and crystal structure1, 63, 64, the 
only solubility data located in the literature and showing the effect of temperature is that 
of di Martino et al.65  Di Martino et al. correctly assert that naproxen sodium exists 
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enantiotropically with its solvates; that is, the solubility curve of one form intersects at a 
transition point with the solubility curve of another form. 
Nevertheless, the work of di Martino et al.65 show some inconsistencies that need 
to be noted.  The data and their interpretation describe anhydrous naproxen sodium 
(ANS) as the thermodynamically stable pseudopolymorph at temperatures below 
10.69°C, meaning that below this point the hydrates would have a higher solubility than 
the anhydrate form.  Nonetheless, when describing the materials used, the manuscript 
states that the dihydrate crystals were obtained by cooling an aqueous solution to 4°C, 
which is well below their claimed transition point.   
The experimental procedure presented by di Martino et al.65 is sound.  They 
measured the solubility of dihydrate naproxen sodium in water through an isothermal 
method with solute concentration determined by UV spectrophotometry.  The estimation 
of the anhydrate solubility was performed by intrinsic dissolution studies, as described by 
Khankari and Grant66, but the data show extremely low solubility values, in addition to 
other inconsistencies in the text.* 
                                                 
* Tabulated values show the slope of cumulative drug release vs. time with µg/min units, when in reality it 
should be µg/min⋅mL.  From the slope values, the intrinsic dissolution rates are then calculated.  The 
dimension error is still carried, and the slope is divided by the surface area for this purpose.  The reported 
intrinsic dissolution rates hence are shown with mol/min/mm2 units, while the values represent 
mol/min⋅mL⋅mm2.  The surface area used for these calculations was 132.73 mm2.  This value is that of the 
tablets’ surface area, according to the authors.  They also explain that only one face of the tablets was 
exposed to the dissolution medium.  If the tablets were disk shaped, then the surface area used for the 
calculations must have been half of the value used.  It is unclear if the authors refer to the 132.73 mm2 as 
the surface area of one face of the tablet.  This would only affect the value of the intrinsic dissolution rates.  
Since the surface area is the same regardless of the tablets, the step for calculating the solubility of the 
anhydrate would cancel the value anyway.  Although these inconsistencies have been found, these should 
not affect the final outcome of solubility determination. 
It is believed that the most probable reason for the low solubility values reported, as well as the behavior 
shown for the rotating disk experiment for the dissolution studies was due to errors in determination 
through UV spectrophotometry.  The results of their dissolution study affect directly their conclusion of a 
transition point at 10.69°C; this because their results show a closer dissolution rate between the anhydrate 
and dihydrate at lower temperatures.  
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  An unpublished study by Kim67 utilized a synthetic polythermal method4, 10 
based on visual inspection and HPLC concentration measurements to determine the 
solubility of naproxen sodium in water over a temperature range from 9.1 to 27.2°C.  For 
this temperature range, dihydrate naproxen sodium (DNS) was found to be the 
thermodynamically stable pseudopolymorph; contradicting the results of di Martino, et 
al.65  Although Kim was unable to determine the transition temperature between 
thermodynamically stable pseudopolymorphs, he concluded that it should be located 
above 27.2°C, the highest solubility limit in his study.    
The work of di Martino et al.65 show data points for the solubility of naproxen 
sodium at 21 °C, 26 °C, 31 °C and 37 °C.  Should the transition point be somewhere 
among their studied range, the authors most probably would have missed it, because of 
their small number of data points. 
 
3.1.2  Methodology 
Barrett, et al.13, 14 presented a method in which a Lasentec Focused Beam 
Reflectance Measurement (FBRM) probe was used to determine the solubility and 
metastable zone widths of potash alum crystals in aqueous solutions.  (Principles of the 
FBRM were discussed in section 2.4).  A clear advantage of the method is that it provides 
reliable and reproducible measurements of the instants of nucleation and dissolution.  
Visual inspection of crystal formation and disappearance by dissolution, while widely 
used, does not have the same precision.  The FBRM method also facilitates estimation of 
the saturation conditions in a solution without using invasive sampling procedures to 
measure concentration.  This aspect also facilitates automation of the process.   
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The following discussion illustrates how the procedure works by describing a run 
from the present work.  Figure 3-1 shows the progression of a single run.  After the clear 
solution has been kept at a temperature above saturation for a predetermined time, the 
temperature is lowered at a constant rate to induce nucleation, an event resulting in the 
formation of numerous small crystals.  The crystals formed are observed by the FBRM 
probe and their chord lengths are measured and counted.  Chord lengths from 1 to 20 µm 
were defined to indicate the nucleation event.  Assuming that the formation of the 
observed crystals did not significantly alter the solution concentration, the relative 
supersaturation at the point of nucleation can be estimated from the solubility and 
measured temperatures.  This information provides an estimate of the metastable limit at 
the specific cooling rate and conditions.  Fujiwara et al. have shown the accuracy of the 
FBRM method for determination of the metastable limit by comparing it to visual and 
ATR-FTIR methods for aqueous solutions of paracetamol, reporting only small 
differences between methods.11 
After observing nucleation the solution is heated at a constant rate, and as shown 
in Figure 3-1, the conditions at which crystals disappear can also be determined.  In the 
present work, coarse counts (50 – 250 µm) were used to indicate the disappearance of 
crystals.  Smaller crystals, having a greater surface area to volume ratio, will dissolve 
faster than bigger ones.  Hence their disappearance into solution would not be a good 





































Figure 3-1.  FBRM data and temperature progression for the naproxen sodium / water system in a batch 
experiment.  Cooling and heating rates for this specific run were set at 0.15°C/min.  Concentration of the 
solution was 145.5 g ANS / kg solution.  The fine counts corresponding to chord lengths from 1 to 20 µm 
were used to determine the point at which nucleation occurred.  The coarse counts corresponding to chord 
lengths between 50 and 250 µm were used to determine dissolution of most of the crystal mass.  The 
behavior shown is typical of runs at other concentrations and cooling/heating rates. 
 
Barrett, et al.13, 14 showed a non-linear behavior for a solution of potash alum 
when temperature of disappearance data was plotted against increasing heating rates.  As 
the heating rate increased, the dissolution of crystals separated further from the solubility. 
For low heating rates (below 0.3°C/min) the data conformed to a linear behavior with a 
positive slope.  As shown in Figure 3.2, similar behavior was observed in the present 
work.  If an infinitesimal heating rate could be applied to the system, the instant of full 
crystal dissolution would occur at the exact saturation point of the system.  This 
infinitesimal heating rate would allow for thermodynamic equilibrium, as the system 
experiences very slow changes in time, rather than a kinetically driven approach, where 





these low heating rates, the saturation point can be estimated by the y-intercept of the 
trendline.  Following this method Barrett et al.13, 14 found their determined solubility for 
potash alum to be in very close agreement with previously published data.68  A 
comparison of the original data with the non-linear regression correlation shown by 
Barrett et al. shows for given saturation temperatures, differences in concentration 
ranging from 7 to 19%.   
Making use of an FBRM D600 probe, the present work focused on the 
determination of the solubility of naproxen sodium in water over a wider temperature 




























Figure 3-2.  Determination of saturation temperature through y-intercept of linear section from data of 





3.2  Experimental 
3.2.1  Equipment 
A jacketed 500-mL glass vessel (9.68 cm ID) with curved bottom was used to 
carry out the crystallization of naproxen sodium.  A four-port head allowed insertion of a 
stirrer, FBRM probe, thermocouple and condenser.  The solution was stirred by a four-
blade 5.1 cm diameter stainless steel propeller with 35° pitch rectangular blades that 
pumped the contents upward for better contact with the FBRM probe.  Stirrer speed was 
maintained at 400 rpm; this provided good mixing with Reynolds numbers ranging from 
11,600 to over 26,000, while avoiding excessive splashing.  Three 0.635 cm diameter 
stainless steel baffles were also used to promote mixing and minimize vortex formation.  
An FBRM D600 was used to observe nucleation and dissolution of crystals.  The 
scanning rate was set to 2 m/s, with 10-second measurement duration and a moving 
average set to 10 measurements.  The probe also served as a baffle.  A condenser with a 
cooling fluid at about 10°C was attached to the vessel to return any solvent that 
evaporated.  A thermocouple was submerged in the solution to record temperature, which 
was acquired through an Omega OMB-DAQ-56 connected to a computer.  The desired 
cooling and heating rates were programmed on a VWR 1157P circulator, which provided 
the temperature control to the vessel.  The upper part of the vessel, between the jacketed 
area and the condenser, was wrapped with a heating cloth maintained at about 50°C 
(higher than the highest solution temperature) to avoid condensation of the solvent 
against the walls and top of the vessel.   The equipment was maintained inside a dark 
fume hood with tinted windows to minimize the possibility of photodegradation of 
naproxen69, 70. 
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3.2.2  Procedure 
Anhydrous naproxen sodium, provided by Albermale Corp., was used without 
further processing or purification.  Water (HPLC grade, purchased from Fisher Scientific) 
was used as the solvent.  To start a set of trials, enough material was included in the 
vessel so that the FBRM probe tip was submerged in the solution.  The first campaign run 
was based on data from Kim67 for saturation conditions at 27.2°C; i.e. at a concentration 
of 240.24 g ANS / kg solution.  Each subsequent run was performed after water had been 
added to dilute the solution.  This was repeated until the solution level reached the top of 
the jacketed area in the vessel.  Following this, the vessel contents were discarded and a 
new campaign was begun at higher saturation temperatures.  Subsequent trial solutions 
were also diluted, and after the solution reached the top of the jacketed area, some of it 
was removed through a lower valve in the vessel.  The mass of solution removed was 
measured so that with the known concentration, the mass of both solute and solvent 
remaining in the vessel was calculated.  More dilutions were then performed for the 
following runs. 
Before any campaign started, the solution was heated until full dissolution was 
achieved.  It was then cooled to initiate crystallization, and subsequently warmed to about 
12 to 15°C above its saturation temperature.  At this temperature the campaign would 
begin.  Every subsequent run would maintain this high temperature for 15 minutes, cool 
at a specific rate to 1 to 3°C below the point of nucleation and immediately heat at the 
same rate to the high temperature, where another run would start at a different cooling 
rate after the 15-minute period at a constant high temperature.  At least three different 
cooling/heating rates (0.15, 0.20 and 0.30 °C/min) were used for each concentration and 
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each of them was repeated three times.  These rates were alternated between runs with no 
specific pattern. 
Barrett and Glennon14 kept their system at the high temperature for 1.5 hours 
between cycles, following a protocol for potash alum developed by other researchers.  
This was done to ensure full dissolution of the solute.  Since the FBRM clearly showed 
full dissolution of the naproxen sodium while temperature was being increased, time 
between runs at a constant high temperature was limited to 15 minutes.   
It has been known that the thermal history of the solution might affect the width 
of the metastable zone.4, 5 For example Nývlt et al. show the effect of solution history on 
the metastable zone width of aqueous KH2PO4 solutions.5  On the other hand, Barrett and 
Glennon14 mention that solution history does not affect the point of nucleation of aqueous 
potash alum solutions, as proven by experimental results.  Solution history effects were 
not studied on this work, henceforth we can only say that the metastable width data 
provided is true for the studied conditions, as with most other published metastable data 
for any system.  The reader is reminded also that besides thermal history of the solution, 
other factors can affect nucleation, such as purity, mechanical action, and dissolved 
admixtures among others.  For a detailed discussion of all these effects the reader is 
pointed to the monograph by Nývlt et al.5  Since the coarse crystals in the solution are in 
equilibrium with the liquid, their disappearance into solution due to the heating process is 
independent of the crystallization conditions; hence the thermal history of the solution 




3.3  Results and Discussion 
The solubility of naproxen sodium in water was determined for a range of 
temperatures from 15.2 °C to 39.7 °C using the procedure described in the previous 
section.  The results are plotted in Figure 3-3.  The data compare favorably to those of 
Kim67 for dihydrate naproxen sodium over the range from 15.2 °C to 28.3 °C.  Over this 
common temperature range the differences between solubilities at specific temperatures 
range between 3 to 10%.  The complete data are given in tabular form in Appendix A.  
The standard errors of the determined saturation temperatures show the high precision of 
the experimental method, ranging from ± 0.11 to ± 0.33 °C.† 
Figure 3-4 shows the solubility curve for DNS along with metastable limit curves 
for different cooling rates.  It can be seen, as explained in Chapter 2, that the metastable 
zone is widened at higher cooling rates.  Figure 3-5 shows the metastable zone widths as 
a function of saturation temperature, reflecting the tendency of the metastable zone to 
widen with lower temperatures.  For example, the difference between the metastable zone 
width of 0.15 and 0.40 °C/min at a saturation temperature of 27.9 °C is 0.7 °C, while at a 
saturation temperature of 17.3 °C it is 2.4 °C.  Similarly Figure 3-6 shows how a higher 
relative supersaturation is required to induce nucleation at lower concentrations.  In 
essence, is “easier” to crystallize a material at a higher concentration than at a lower one.  
For faster cooling rates, and lower concentrations, the relative supersaturation at 
nucleation of dihydrate naproxen sodium can easily exceed a value of 1.   
 
                                                 
† Standard errors were calculated for the y-intercepts (estimated saturation temperatures) based on the line 
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Figure 3-6.  Relative supersaturation necessary to induce nucleation for solutions of naproxen sodium in 
water in cooling batch crystallization.  Equilibrium concentration values for 104.3 and 121.5 g ANS / kg 
solution were estimated from multiple regression of solubility. 
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Kim estimated that the transition point between DNS and the next lower hydrate 
in the enantiotropic phase diagram of naproxen sodium was above 27.2°C, which was the 
upper temperature limit of his work.67  A closer look at the data found in the higher 
temperature range of the present work, as seen in Figure 3-3, reveals a slight difference in 
solubility behavior at higher temperatures.  The van’t Hoff plot of the data in Figure 3-7 
shows a discontinuity between the dihydrate line at the right and the next form at the left. 
The linear fits show correlation coefficients of 0.9993 and 0.9991 for the dihydrate and 
the other pseudopolymorph, respectively.  The lines intersect at 29.8 °C indicating the 



















Figure 3-7.  Van’t Hoff plot for naproxen sodium solubility data. 
 
A separate experiment was conducted at a concentration of 333.7 g ANS / kg 
solution, with a cooling rate of 0.2 °C/min with the purpose of identifying the stable 
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pseudopolymorph in the higher temperature range.  A sample of the crystallized material 
was vacuum filtered, washed with cyclohexane to flush water from the crystals, and dried 
at room conditions for 24 hours.  Powder X-ray diffraction (PXRD) was performed on a 
sample of the dried material with a Phillips PANalytical X’Pert PRO (CuKα radiation, 
1.541 Å wavelength).  PXRD patterns showed peaks that coincide with DNS and ANS 
according to findings by Kim, et al.2 (Fig. 3-8).  Monohydrate naproxen sodium (MNS) 
peaks were not distinctively identified, but some of these coincide with those of the two 
other forms at lower intensities. 
















Figure 3-8.  PXRD patterns for ANS, MNS and DNS by Kim67 and for the experiment performed at a 
concentration of 333.7 g ANS / kg solution (Tsat = 36.9 °C). 
 
These results can be interpreted in different ways.  For example, the metastable 
limits between ANS and DNS are very close at the supersaturation level and conditions 
of the experiment, so that cooling produces both forms of crystals.  On the other hand, if 
only ANS had been produced, there are two alternative possibilities: (1) a solvent 
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mediated transformation had begun at the moment of filtering at room temperature 
(approx. 24 °C), or (2) the crystals were hydrated from moisture in the air while drying 
and transformed into the most stable hydrate at ambient conditions, i.e. DNS.  Regardless 
of the transformation or crystallization mechanism, we can conclude that ANS is the 
stable form at the higher studied temperature range.   
In the preceding explanations we neglected to mention MNS.  Clearly, it is either 
unstable at the studied temperature range, or it is stable only over a very small 
temperature range that was undetected by this study.  Results by Kim67 suggest that the 
stability of the monohydrate increases up to a certain extent in solutions of 
methanol/water.  We explore the possibility of MNS being unstable in aqueous solutions 
at the studied temperature range in the following discussion. 
The van’t Hoff relationship in Fig. 3-7 is based on the equation 












soln                                             (3-1) 
where x is the solubility in terms of mole fraction, ∆Hsoln is the apparent enthalpy of 
solution, R is the ideal gas constant, Tm is the melting point, and T is the saturation 
temperature corresponding to x, with both temperatures in absolute scale.  Therefore, the 
slope of the plot is ∆Hsoln/R, and the apparent enthalpies of solution for both forms of 
naproxen sodium can easily be calculated as 56,185 J/mol for the dihydrate and 33,773 
J/mol for the other form.  Kim67 determined from his solubility data a heat of solution for 
the dihydrate of 49,928 J/mol.  The differences between DNS enthalpy of solution in 
these two studies can be attributed to different experimental methods. 
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Although a fit of the van’t Hoff equation to the data seems to be a fine approach 
to observe changes in solubility behavior, its use should be restricted to ideal systems.4  
Furthermore, this method assumes the apparent enthalpy of solution as independent of 
temperature.  Grant et al.71 recommend a multiple regression model to fit solubility data 
that allows the determination of apparent thermodynamic parameters ∆Hsoln and change in 
heat capacity, ∆Cp.  The model fits the data to the equation 




ax ++⋅−= ln1ln                                            (3-2) 
where a, b and c are coefficients determined from the regression.  ∆Hsoln can then be 
determined as a linear function of absolute temperature 
                                                          bTaH +=∆ soln                                                   (3-3) 
rather than the constant value given by the van’t Hoff method, and ∆Cp as the b 
coefficient, or 
                                     bCCC ppp =−=∆ solute) pure()solution(                               (3-4) 
Figure 3-9 shows the solubility data accompanied by the trends based on multiple 
regressions.  Table 3-1 summarizes the results for both species.  The ∆Hsoln values found 
with the van’t Hoff equation fall within the limits of the studied temperature ranges for 
both species as determined by Equation 3-3; the 56,185 J/mol determined for the 
dihydrate is representative of a temperature of 22.0 °C, while the 33,773 J/mol of the 
anhydrate will be for a temperature of 34.9 °C.  These temperature values coincide with 
the averages of the experimental saturation temperature ranges, namely 21.8 and 35.0 °C.  
For the studied saturation temperature ranges, 15.2 °C to  28.3 °C for DNS and 30.3 °C to 
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39.7 °C for ANS, ∆Hsoln according to equation 3-3 ranges from 58,977 J/mol to 53,582 































Figure 3-9.  Solubility data for the naproxen sodium species and their curves as derived from multiple 
regression analysis.  
 
Table 3-1.  Coefficients found for naproxen sodium through regression analysis. 
 
 Dihydrate Anhydrate 
a [J/mol] 177,731 -138,885 
b = ∆Cp [J/mol K] -411.84 560.53 
c [dimensionless] 349.89 -443.99 
% Max error‡ 0.39 0.11 
 
By finding the point of intersection of the two curves from the multiple 
regressions, or simply by equating them, we obtain a transition temperature between DNS 
and ANS at 30.3°C.  This value differs from the one found with the van’t Hoff method by 
0.5°C. 
                                                 
‡ The percentage of maximum error refers to differences between the data and the regression for the ln x 
values. 
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Figure 3-10 shows the solubility data and multiple regression fittings for the two 
species accompanied by their respective experimental metastable zone widths.  From this 
we can observe closely the interaction of the metastable zones near the transition point.  
For example, a saturated solution at 30 °C can be cooled down to 26 °C to obtain crystals 
of ANS, while cooling to 25 °C or below might render a mixture of both species.  The 
reader is referred to Threlfall’s article33 for further discussion about enantiotropic phase 
diagrams and their metastable zones.  Since the metastable limit can only be extrapolated 
for DNS at higher saturation temperatures, we cannot precisely determine the proximity 
of the metastable limits for both forms and only speculate from the results that it is a 






























Metastable limit at 0.15 °C/min
Metastable limit at 0.20 °C/min
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Anhydrate solubility
Metastable limit at 0.15 °C/min
Metastable limit at 0.20 °C/min
Metastable limit at 0.30 °C/min
 




3.4  Conclusions 
The solubility of naproxen sodium in water was determined with a Lasentec 
FBRM for a range of 15.2 to 39.7°C.  The transition point between the DNS and ANS 
was obtained with the acquired data through two different models, van’t Hoff and 
multiple regression fittings, at 29.8 and 30.3 °C respectively.   Metastable zone and 
relative supersaturation behavior conforms to theory.  Enthalpy of solution and change of 
heat capacity were also estimated.   
It is recommended that further experimentation be performed for even a wider 
range of temperatures than those studied here, with particular focus in saturation 
concentrations near 30°C.  This would help in determining the stability (or lack thereof) 
of MNS.    
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CHAPTER 4 
PROCESS MONITORING AND CHARACTERIZATION OF PARACETAMOL 
AND D-MANNITOL CRYSTALLIZATIONS:  BATCH AND LAMINAR-FLOW 
TUBULAR CRYSTALLIZERS 
 
 A Lasentec FBRM probe was used to monitor the formation of paracetamol 
(acetaminophen) and D-mannitol in two types of crystallizer configurations: (1) a batch 
system that was cooled at four different rates and (2) a system in which a cooled, 
laminar-flow tubular unit preceded a batch vessel that was held at the same low 
temperature as the jacket of the laminar-flow unit.  The latter configuration is referred to 
here as a laminar-flow tubular crystallizer (LFTC) because supersaturation was generated 
in the tubular unit preceding the batch-operated vessel.  Because of the rapid rate at 
which supersaturation was generated in the LFTC, the resulting crystals were of smaller 
mean size than those obtained from batch crystallizations.  The total time required to 
relieve all of the generated supersaturation (i.e., produce a fixed mass of crystals) was 
significantly less with the LFTC than with the batch unit.  Additionally, paracetamol was 
produced as two different polymorphs in the LFTC, Forms I and II.  The production of 
the different forms resulted from the rapid rate at which supersaturation was generated in 
the LFTC, although the evidence suggests that solvent-mediated transformation of the 
less stable polymorph, Form II, to the more stable Form I took place in the batch vessel 




4.1  Introduction 
4.1.1  Background 
Processes involving crystallization are common in pharmaceutical, specialty 
chemicals and food industries.  Many companies have attempted to improve their 
processes through the design of novel apparatuses and methodologies.72-74 Crystal size 
and polymorphism control are often among the objectives of novel process design.   
In the pharmaceutical industry, crystal size becomes important in considerations 
related to drug dissolution rate and tableting properties.22, 75-77 When the attained particle 
size is greater than desired, another downstream process, such as milling, is required to 
reduce it.  Milling processes can also affect unfavorably the properties of the crystals, 
transforming them in some instances into other polymorphs or amorphous materials.28   
Differing physical properties of polymorphs of the same molecular species affect 
bioavailability, encapsulation, and dissolution rates.  In some cases, obtaining an 
undesired polymorph has proven to be very counterproductive for companies.29 Hence 
there has been an effort in industry and academia to find methods to control 
polymorphism by change of solvents, crystallizer design,3, 26, 27 seeding,23, 78 additives,24, 
79, 80 and other methods. 
Work by Brenek et al.,3 addressed the situation of morphology control, both in 
terms of crystal size and polymorphism, by the use of a laminar-flow tubular crystallizer 
(LFTC) for the recrystallization of a pharmaceutical product.  The present work revisits 
the concepts suggested in the work of Brenek et al.3 by comparing the outcomes from 
crystallizations performed in LFTC and batch units.  Several crystalline species were 
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included in the study.  Of these species, the present chapter will focus in paracetamol 
(acetaminophen) and D-mannitol.  Other species studied are mentioned in Appendix B.  
 
4.1.2  Laminar-Flow Tubular Crystallizer 
The LFTC resembles a tube-in-tube heat exchanger which transports the solution 
of interest through the inner tube, while cooling with water flowing countercurrently 
through the outer tube.  The small size of the inner tube (3.175 mm ID) compared to the 
size of the outer tube (11.11 mm ID), the length of the crystallizer (7.62 m) and the 
velocity of the fluids (10.8 to 47.2 mL/min inside, 1.27 L/min outside), allow efficient 
heat transfer between the fluids with minimum temperature change in the cooling fluid.  
(Heat transfer models of the system are explained in Appendix C). 
As discussed in Section 2.2, higher cooling rates in batch systems increase the 
width of the metastable zone.  Furthermore, a fast initial cooling can push the system to 
cross the metastable limit promoting uncontrolled crystallization and the formation of 
fines.  Often in batch crystallization this is not desired; instead, a constant supersaturation 
is used to provide a narrow size distribution with a large mean crystal size, sometimes 
aided by seeding.7  One purpose of the LFTC is to produce crystals with a smaller size 
than typically obtained from well-mixed batch systems.  This is possible due to the high 
supersaturation that the solution reaches shortly after entering the LFTC.§  High 
supersaturation levels are maintained during most of the length of the crystallizer and 
while the solution (or slurry) is contained at a receiving vessel, where the supersaturation 
is consumed and yield is maximized. 
                                                 
§ See Appendix C for more details about heat transfer in the LFTC and its relationship to supersaturation. 
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Because the LFTC experiences laminar-flow, we expect velocity profiles along its 
length, or a gradient as seen from the axial direction.  This means that the material at the 
center of the tube will spend less time inside the LFTC than that along the walls.  For 
Newtonian fluids traveling along the length z through a circular tube with laminar-flow, 





v =                                                         (4.1) 

















rvv zz                                                 (4.2) 
where zv is the average velocity, max,zv  is the maximum velocity, zv is the velocity at a 
radius r and R is the radius of the tube.  The model assumes no changes in the properties 
of the fluid along the length of the tube and “no-slip” conditions along the walls.  
Following these equations, velocity profiles for the different average flow rates can be 
easily determined for the LFTC.  Figure 4-1 shows the velocity profiles for three different 
flow rates on the LFTC.  As is apparent from the figure, flow through the LFTC deviates 
greatly from plug flow.  The non-uniform velocity distribution contributes to the axial 
dispersion of the solution.  If a tracer were to be injected into the LFTC at normal 
operation, the convection effect due to the velocity variation across the cross section 
would disperse the tracer axially.  Such dispersion can be modeled in terms of the 
concentration distribution of the tracer.  The mathematical model for axial dispersion in 
laminar tube flow was originally developed and verified experimentally by Taylor81 in 
1953.  A recent publication by Ekambara and Joshi82 reviews the significant amount of 

























Figure 4-1.  Velocity profiles for different flowrates in the LFTC. 
 
In the event of crystal nucleation inside the tube, the axial dispersion resulting 
from the parabolic velocity profile would result in the production of smaller crystals at 
the center of the tube, where the solution resides the least amount of time.  Crystal size 
would then increase as the profile approaches the wall of the tube.  As we will see, this 
can also be explained quantitatively with the assistance of residence time distributions 
(RTD). 
For laminar-flow systems, like the LFTC, the age RTD E(t) function is 
                                                  E(t) =        
2
         
2
2











                                           (4.3) 
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where t is time and tm is the mean residence time, as defined by the total volume of the 
LFTC’s inner tube over the average flow rate (or length of the LFTC divided by the mean 
velocity).  (A complete derivation of the equation can be found elsewhere).83  Figure 4-2 
shows the RTDs for three different flow rates in the LFTC used in the present study.  The 
plot is useful for better understanding of the flow patterns in the crystallizer.  For 
example, for a volumetric flow rate of 44.5 mL/min, we see that the vertical asymptote 
reaches a value of 10.17 seconds, the time that it takes for a point of solution to go 
through the LFTC right at the center of the tube, where the velocity is at its maximum.  
For this flow rate, the mean residence time is 20.34 s.  If we integrate the area under the 
curve between 10.17 s and 20.34 s, we find that 75% of the feed to the system resides in 
the LFTC between these two times.  This type of information can also be acquired 
through a cumulative RTD F(t) plot, in which, 
                                                F(t) =        
2















                                        (4.4) 
 
Figure 4-3 shows this type of plot for three different flow rates through the LFTC.  
Taking again the 44.5 mL/min example, we can see how F(t) goes from 0 to 0.75 in the 






















Figure 4-2.  Residence time distribution for different flowrates through the LFTC.  Mean residence time 






















Figure 4-3.  Cumulative residence time distribution for different flowrates through the LFTC. 
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As we see from the RTD, the solution does not spend a uniform amount of time in 
the LFTC and therefore, we cannot assume that the formed crystals will have a narrow 
size distribution.   
Although experiments with plug flow were not performed, it is significant to 
bring to the attention of the reader the importance of such flows in terms of size 
distributions and RTD.  In plug flow, turbulent flow inside the tube would result in no 
axial dispersion effects, translating into a narrow age function E(t).  This is generally 
represented by a spike in the RTD plot.  Velocity then is not represented by a parabolic 
profile like in laminar-flow, but rather by a flat plug.  Because plugs of material travel at 
the same speed and with the same residence time, in the event of nucleation, the formed 
crystals should have the same size, hence a narrow distribution. 
 
4.1.3  Polymorphism 
In 1897 Wilhelm Ostwald published what has been known as the Ostwald rule of 
stages.35  He explained that in a polymorphic system, the first polymorph to crystallize 
would be the one that is kinetically stable (or “unstable”), rather than the one that is 
thermodynamically stable (although there are numerous exceptions to the rule).  In other 
words, in crystallization, a system will go to that state in which the loss of free energy is 
minimal.  When the unstable polymorph is obtained and left in solution for a sufficient 
amount of time, a solvent-mediated transformation might occur, in which crystals 
redissolve to crystallize this time as the thermodynamically stable species.  Hence, if the 
unstable polymorph is desired, the crystals must be isolated by filtering and drying.**  As 
                                                 
** Some materials might convert to another polymorph in certain temperature and pressure conditions, even 
when they are not in a solution, through a solid-state transformation. 
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discussed in Section 2.3, because an unstable polymorph at a certain set of conditions 
would have a higher solubility than the stable one, a fast cooling with high 
supersaturation levels would then enable the crystallization of the unstable polymorph at 
a particular temperature range.  Brenek et al.3 were able to produce and isolate an 
unstable polymorph of a pharmaceutical product utilizing a LFTC without concomitant 
production of the stable form, while at the same time producing crystals of smaller size 
than those produced in a batch crystallizer.  They did not have to add seed crystals of the 
metastable material in order to produce it. 
 
4.1.4 Materials used 
4.1.4.1  Paracetamol 
Paracetamol (acetaminophen) is a widely used antypiretic and analgesic often 
found in over-the-counter drugs.  Three polymorphs of paracetamol have been identified, 
with the monoclinic crystal (Form I) being stable at room conditions.  Much attention has 
been focused on the production of Form II, an orthorhombic crystal, whose sliding planes 
allow it to have much better compressibility than Form I.77  The monoclinic form used in 
drug products lacks sliding planes and requires binding agents for the tableting process, 
which adds cost to its production.75, 77  Form II has been obtained by crystallization from 
melts,77 yet this process is disadvantageous for production on large scale.  For this reason 
Nichols and Frampton75 focused on the production of Form II from ethanol solutions in 
laboratory-scale batch crystallizers with the assistance of seeds obtained from melting 
crystallization.  The researchers found that an unseeded batch would yield Form I, and 
that solvent-mediated transformation from Form II to I can occur easily.  They 
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recommended crystallizing at temperatures below 5 °C to retard the transformation 
process.  Due to these difficulties, the authors noted that there is a need for extensive 
optimization for process scale-up.  Other researchers78, 84 have then looked to optimize 
the parameters to maximize the formation of Form II in batch crystallizers.  Form III 
crystals have been obtained by melting crystallization and have proven to be elusive to 
isolate and retain for characterization.75, 77, 85 
 
4.1.4.2  D-mannitol 
D-mannitol is an acyclic alcohol commonly used as an excipient in tablets by the 
pharmaceutical industry.  Its non-hygroscopic characteristics make it useful as an 
excipient for moisture sensitive drugs.  It is also commonly used in chewable tablets that 
rapidly dissolve in the oral cavity; its negative heat of solution gives a cooling sensation 
in the mouth.86  Three different polymorphs have been identified for D-mannitol, here 
referred as α, β and δ, following the nomenclature by Walter-Lévy.87  All three forms 
have been characterized by multiple methods, including powder XRD, DSC, FTIR, and 
FT Raman among others.22, 86, 88-90   
Crystallization protocols can also be found in the literature for all three forms.  
The β polymorph, which is stable at room conditions, can be easily obtained by cooling 
batch crystallization, and is the usual commercial product.22  The α form can be obtained 
by crystallization from 70% ethanol.22  The δ polymorph can be produced by cooling 
rapidly a hot saturated solution of D-mannitol (for example, in water,22 dilute aqueous 
acetone solution,86 or dilute aqueous ethanol solution88) to 0 °C or below, and filtering 
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rapidly.  It also can be obtained by precipitation from an aqueous solution by adding 
acetone or by freeze-drying.22   
Although it has been reported that moisture can induce transition of the δ form of 
D-mannitol to the more stable β polymorph,86 it has also been shown that it is the form 
with better tableting behavior of the three.22  Although at room conditions it is 
thermodynamically unstable, it shows great kinetic stability, by being durable over a 
period of at least 5 years at 25 °C if kept dry.  Also, mechanical stresses, such as grinding 
and tableting, do not cause a transition of the δ polymorph to either of the other forms.22 
Taking these two examples, paracetamol and D-mannitol, we can see how 
important it is to find crystallization processes that are able to produce and retain an 
unstable polymorph. 
 
4.1.5  Process monitoring 
 As part of the characterization process, a Lasentec FBRM D600 along with online 
temperature recording were used to acquire chord-length and nucleation-relevant data in 
both batch and LFTC operations.   
 For the purpose of relative size comparisons throughout this chapter, we will use 
the median and mean values of the chord length distribution (CLD) obtained by the 
FBRM.  No weighting was applied to either value, and therefore they represent number 
average quantities.  
A method described by Euhus91 was used in this work to relate the zeroth moment 
of the chord-count density function to the nucleation rate of the systems under study.  The 
derivative of the total number of crystals with respect to time is, by definition, the 
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nucleation rate.  The method is hereon briefly described, but the reader is directed to the 
work of Euhus91 for further details. 
  Based on a population density function, a chord-count density function c(l) is 
defined as,  







lim                                                (4.5) 
where ∆C(l) is the number of chord counts with lengths between l and l + ∆l in the 
volume of slurry or liquid scanned by the FBRM probe, SV .  This volume is defined on 
estimates of the scanning specifications of the probe.  These specifications are: the depth 
that the laser beam effectively penetrates λ, its width b, and its scan speed along the path 
Sv& .  Then, the volume scanned over any period of time ∆t can be approximated by the 
equation, 
                                                           tbvV SS ∆λ= &                                                 (4.6) 
Values used in this work for the aforementioned variables were, λ = 1.50×10-3 m, b = 
5.80×10-6 m, and Sv&  = 2 m/s. 
Randolph and Larson46 have shown that the zeroth moment of the population 
density function is related to the total number of particles per unit volume.  Using a 
chord-count density function allows us to do the same, since the number of chords 
registered by the FBRM should be identical to the total number of crystals in a specific 
scanned volume.  The zeroth moment 0m  of the chord-count density function is, 




0 cdlm                                                    (4.7) 
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which is the total number of particles per unit volume Ntotal.  By neglecting crystal 
attrition and agglomeration, the nucleation rate J0 in a well-mixed vessel is, 





J total 00 ==                                           (4.8) 
 By considering CLD data from the FBRM, where counts per second are relayed in 
specific chord lengths, a simple spreadsheet can be developed in which the zeroth 
moment is calculated based on the effective scanned volume.  The derivative of these 
zeroth moments over time, would then give us the nucleation rate of the system.  As seen 
in Figure 4-4, the derivative of the zeroth moment, increases rapidly, reaches a maximum 
value, and then decreases rapidly to a near-zero value.  In this study the characteristic 



































































































Figure 4-4.  Zeroth moment analysis for determination of nucleation rate.  This graph pertains to a run of 
paracetamol in methanol on the LFTC with crystallization occurring in the receiving vessel. 
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4.2  Materials 
 Paracetamol (4-acetamidophenol 98%) was purchased from Acros Organics.  D-
mannitol, ACS, 99.0% minimum was purchased from Alfa Aesar.  Ethanol 200° proof 
was purchased from Equistar Chemicals LP.  Methanol USP was purchased from 
Chemcentral.  Mega-pure water from a Barnstead system was also used. 
  
4.3  Experimental 
4.3.1  Batch Crystallization 
4.3.1.1 Equipment 
A jacketed 500-mL glass vessel (9.68 cm ID) with curved bottom was used to 
carry out the batch crystallizations.  A four-port head allowed insertion of a stirrer, 
FBRM probe, thermocouple and condenser.  The solution was stirred by a four-blade 5.1 
cm diameter stainless steel propeller with 35° pitch rectangular blades that pumped the 
contents upward for better contact with the FBRM probe.  Stirrer speed was maintained 
at 400 rpm; this provided good mixing with Reynolds numbers ranging from 10,000 to 
over 43,000 (depending on temperature and solvent), while avoiding excessive splashing.  
Three 0.635 cm diameter stainless steel baffles were also used to promote mixing and 
minimize vortex formation.  An FBRM D600 was used to observe nucleation and chord 
length distributions (CLD) of crystals.  The scanning rate was set to 2 m/s, with 10-
second measurement duration and a moving average set to 10 measurements.  The probe 
also served as a baffle.  A condenser with a cooling fluid at about 10°C was attached to 
the vessel to return any solvent that evaporated.  A thermocouple was submerged in the 
solution to record temperature, which was acquired through an Omega OMB-DAQ-56 
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connected to a computer.  The desired cooling rates were programmed on a VWR 1157P 
circulator, which provided the temperature control to the vessel.  The upper part of the 
vessel, between the jacketed area and the condenser, was wrapped with a heating cloth 
maintained at about 85°C (higher than the highest solution temperature) to avoid 
condensation of the solvent against the walls and top of the vessel. 
 
4.3.1.2 Procedure 
 Both solute and solvent under study were introduced into the batch vessel at room 
temperature, with sufficient amount of material so that the FBRM probe tip was 
submerged in the solution.  Following this, the vessel was heated until full dissolution 
was achieved, then cooled to allow crystallization, and heated again to the desired 
temperature set point at which the solution was to remain for 30 minutes prior to cooling 
at a specific rate for the first experiment in a campaign.  Data recording by FBRM and 
temperature acquisition took place from the constant high temperature period until a time 
following nucleation at which the system had reached equilibrium; this was determined 
by FBRM monitoring of chord lengths and their mean and median values.  Subsequently, 
the slurry was heated to the high temperature set point, to remain there for 30 minutes, 







4.3.2  Laminar-Flow Tubular Crystallizer System 
4.3.2.1  Equipment 
 Figure 4-5 depicts the design of the tubular crystallizer system.  A small vessel 
(A) of approx. 75 mL, was used to contain the solvent for flushing purposes.  A 250-mL 
baffled glass vessel (B) contains the feed solution.  The solution and/or solvent are 
pumped through the tubular crystallizer (D) with a FMI QG400 positive displacement 
pump (C) with jacketed head that allows the liquid to remain warm.  The tubular 
crystallizer is made of a 7.62 m long inner PTFE tube (1.5875 mm ID, 3.175 mm OD), 
which transports the solution, surrounded by a 11.11 mm ID (12.70 mm OD) PTFE tube 
containing the heat-transfer fluid in counterflow.  The LFTC is coiled together in a 
circular fashion, and covered by two layers of 0.95 cm elastomeric foam wrap to 
minimize the heat transfer with the surroundings.  The receiving vessel (E) is the same 
one used in the batch experiments, with the same setup, with the exception of not having 
the heating cloth.  Temperature was controlled through the use of thermobath circulators 
maintained at the desired constant temperatures, following the layout shown in Figure 4-
5.  Heating tape maintained at the hot temperature was used between the outlet of the 
solution vessel and the three-way valve to avoid heat losses.  Temperature was recorded 
at the solution vessel, receiving vessel, and inlets and outlets of solution and heat transfer 





Figure 4-5.  Laminar-Flow Tubular Crystallizer System. 
 
4.3.2.2  Procedure 
Prior to starting an experiment, the thermobath circulator temperatures were set at 
a high temperature for the pump head, solution vessel and solvent vessel, and a low 
temperature for the crystallizer and receiver.  Similar amounts of solvent and solute that 
had been used in batch experiments were added to the solution vessel after the set 
temperatures were reached.  Solvent and solute were stirred for a period of 30 minutes 
while the solute was dissolved in its entirety.  While the solution was stirred the LFTC 
was flushed with warm solvent from the solvent vessel.  This solvent was recovered from 
the outlet of the LFTC to another vessel, such as a beaker, and discarded.  After the 
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LFTC, the pump was turned off and the outlet tube was introduced into the receiving 
vessel.  When the 30 minutes of stirring the solution had passed, temperature data 
collection was started.  The solution was then pumped through the crystallizer by 
switching the three-way valve to the solution vessel, opening the lower valve of the 
vessel and turning on the pump.  Typical flow rates ranged from 10.8 to 47.2 mL/min 
(Table 4-1 shows the Reynolds numbers for flow through the LFTC according to the 
studied flow rates).  To minimize the presence of remaining solvent from the flushing 
stage, the first drops coming out of the LFTC were discarded through the lower valve of 
the vessel.  Following these drops, no flow of solution was detected for some seconds 
until the actual solution under study came through.  The cold solution was then recovered 
in the receiver vessel, where data was collected through the FBRM while the 
supersaturation was consumed and crystallization occurred.  A run was considered 
complete when the system reached equilibrium, which was defined to be when the mean 
and median chord lengths became constant. 
 
Table 4-1.  Reynolds numbers for the LFTC flow based on solvents. 







11.9 310 10.8 220 15.6  470 
28.2 780 26.7 530 30.4 920 
45.5 1260 42.9 850  47.2 1420
 
 
4.4  Results and Discussion 
A complete summary of data and results used in this section can be found in 
Appendix D. 
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4.4.1  Paracetamol 
Solutions of paracetamol in ethanol were prepared by dissolving 59.54 g of the 
solute in 175 g of the solvent (34.02 g / 100 g ethanol).  Data from a recent publication92 
were used to estimate the saturation temperature at this concentration as 50.6 °C.  For 
methanol solutions, 90.44 g of paracetamol were dissolved in 162.5 g of the solvent 
(55.66 g / 100 g methanol).  Since solubility data at this concentration were not found,  
extrapolation using a van’t Hoff fit of data by Granberg and Rasmuson93 resulted in an 
estimate of the saturation temperature to be 52.6 °C.  Solubility data are shown in Figure 
4-6 as van’t Hoff plots.   
 
ln x = -1836.8 (1/T) + 3.3078
R2 = 0.9942

















) Solubility in Ethanol
Solubility in Methanol
 
Figure 4-6.  Solubility data for paracetamol in ethanol and methanol.  Van’t Hoff fits are shown with their 
corresponding regression equations for estimation of solubility.  (Solubility data in ethanol from 




4.4.1.1  Batch Crystallization 
Batch runs were initiated at a high temperature of approximately 69.5 °C and 
cooled to approximately 11.5 °C at cooling rates of 0.15, 0.20, 0.30 and 0.40 °C/min.  
These batch experiments focused on studying the effects of solvent and cooling rate on 
batch crystallization of paracetamol.  
Recrystallization of paracetamol (Form I) from ethanol and methanol solutions 
produced crystals with a prismatic shape, as seen in Figure 4-7.  The morphology of these 
crystals differs from that of Form II which is needle-shaped.  The figure, although not 
entirely representative of the size distribution, shows indications of its broadness as we 
see from the different sizes. 
 
 
Figure 4-7.  Paracetamol crystals obtained from batch crystallization of paracetamol from an ethanol 
solution cooled at 0.15 °C/min.  The sample does not necessarily reflect the actual size distribution of the 
entire batch.  (Image at 4x magnification). 
 
 56
  Figures 4-8 and 4-9 show the median and mean chord lengths at equilibrium as 
recorded by the FBRM for the batch crystallization of paracetamol from ethanol and 
methanol at the studied cooling rates.  Both median and mean chord lengths at 
equilibrium are reduced with higher cooling rates in batch operation.  In other words, 
faster cooling rates promoted the formation of finer crystals.  Comparison of chord length 
distributions at equilibrium obtained at different batch cooling rates, as seen in Figure 4-
10 for the crystallization from ethanol, also show that with higher cooling rates an 
increment in counts is observed, hence a greater number of crystals.  While the number of 
crystals increases their mean size is also reduced, as can be observed from the shift and 






















Figure 4-8.  Median (no weight) values (at equilibrium) for the CLD of paracetamol crystallized from 























Figure 4-9.  Mean (no weight) values (at equilibrium) for the CLD of paracetamol crystallized from 




























Figure 4-10.  Chord length distributions at equilibrium for paracetamol crystallized from ethanol solutions 




Figure 4-11 shows the relationship between cooling rate and nucleation rate.  The 
formation of fines proceeds at a faster rate than the formation of coarse crystals, so it 
follows that higher cooling rates will translate into higher nucleation rates, as observed in 

























Figure 4-11.  Nucleation rates determined by zeroth moment analysis for paracetamol crystallized from 





 Perhaps the most interesting finding while observing these data (Figures 4-8, 4-9 
and 4-11) is the shift in mean crystal size and nucleation rates between ethanol and 
methanol solutions at cooling rates ranging from 0.30 to 0.36 °C/min.  After these 
cooling rates the curves describing CLD median, mean and nucleation rate intersect to 
denote a shift between the relationships of the two systems.  Figures 4-8 and 4-9 show 
how the crystal size is smaller for paracetamol crystals obtained from methanol solutions 
than those from ethanol solutions below these cooling rates, and how there is an inversed 
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relationship afterwards.  This would indicate then that for appropriate fine crystal size 
control in batch operation, a selection of solvent and cooling rate must be chosen to 
satisfy the optimal requirements.  For example, if it is required to cool at 0.40 °C/min, 
and slightly smaller crystals are desired, then ethanol should be the solvent of choice.  Or 
if smaller sizes are required, but with the use of methanol as the solvent, then lower 
cooling rates are recommended. 
At a cooling rate of 0.40 °C/min, the nucleation rate determined for paracetamol 
crystallized from methanol was higher than that from ethanol.  Nonetheless, the crystals 
obtained from methanol were of greater mean size than from ethanol in terms of their 
CLD.  This does not necessarily reflect a contradiction to the general understanding that 
higher nucleation rates are linked to smaller mean crystal sizes.  The reader is reminded 
about the differences between the two systems, namely in terms of solvent, concentration 
and solubility, which can affect the dynamics of crystallization.  Nevertheless, it is 
unclear if this behavior is due to measurement inconsistencies. 
Figure 4-12 shows the trend of nucleation temperature at different cooling rates 
for the studied concentrations.  We can observe a decrease in nucleation temperature with 
higher cooling rates.  In other words, cooling at a faster rate would promote nucleation at 
a lower temperature than when cooling at a slower rate.  As can be observed from the 
figure, there is about a 10 °C difference in the nucleation temperature between cooling 






























Figure 4-12.  Average nucleation temperatures for paracetamol crystallized from ethanol and methanol 
solutions. 
 
This tendency of lower nucleation temperatures with higher cooling rates can also 
be appreciated in terms of the metastable zone width.  Figure 4-13 shows the temperature 
at which nucleation occurred for each cooling rate examined; in other words, it shows the 
width of the metastable zone, for the particular set of conditions experienced in these 
batch runs.  As it can be clearly observed, the metastable zone widens with higher 
cooling rates.  For paracetamol in methanol solutions we can observe, for example, how 
there is a 1.19 °C metastable limit for a cooling rate of 0.15 °C/min, and how this is 
expanded to 11.38 °C at a cooling rate of 0.40 °C/min.    For ethanol solutions the 
metastable zone width increases substantially when compared to the methanol solutions.  
For cooling rates of 0.15 °C/min the width of the metastable zone is 14.96 °C; even 
higher than the one obtained for 0.40 °C/min cooling rates with the methanol solutions.  
 61
This gets even more accentuated when we observe the 24.83 °C metastable zone width 



























0.15 °C/min Nucleation Temperature (Ethanol)
0.20 °C/min Nucleation Temperature (Ethanol)
0.30 °C/min Nucleation Temperature (Ethanol)
0.40 °C/min Nucleation Temperature (Ethanol)
Solubility (Methanol)
0.15 °C/min Nucleation Temperature (Methanol)
0.30 °C/min Nucleation Temperature (Methanol)
0.40 °C/min Nucleation Temperature (Methanol)
 
Figure 4-13.  Solubility and metastable limits at different cooling rates for paracetamol crystallized from 
ethanol and methanol solutions. 
 
It is also appropriate to discuss this behavior in terms of supersaturation.  
Departing from nucleation temperature data, Figure 4-14 depicts the relative 
supersaturation of the systems at nucleation.  (Results are also summarized in Table 4-2).  
The required supersaturation for nucleation of paracetamol in methanol is significantly 
lower than that of the solute in ethanol.  As can be deduced from the nucleation 
temperature data, the relative supersaturation required for nucleation to occur is higher at 
higher cooling rates.   For an infinitesimal cooling rate, the relative supersaturation 
necessary for nucleation can be estimated as 0.23 for the ethanol solution and 0.005 for 
the methanol solution, based on extrapolation of exponential fits of the data shown in 






































Figure 4-14.  Relative supersaturation at nucleation for the crystallization of paracetamol from ethanol and 
methanol solutions.  Relative supersaturations were calculated from nucleation temperature data and 
solubility calculations from van’t Hoff fits of published data.92, 93 
  
Table 4-2.  Summary of averaged data of nucleation temperature, metastable zone width and relative 
supersaturation at nucleation for paracetamol, 34.02 g / 100 g ethanol and 55.66 g / 100 g methanol, for the 















Paracetamol / 0.15 35.64 14.96 0.35 
Ethanol 0.20 34.82 15.78 0.37 
  0.30 31.37 19.23 0.48 
  0.40 25.77 24.83 0.67 
Paracetamol / 0.15 51.41 1.19 0.02 
Methanol 0.30 49.45 3.15 0.06 
  0.40 41.22 11.38 0.23 
 
Figure 4-15 shows how relative supersaturation of paracetamol changed with time 
in the batch crystallizer.  The values of relative supersaturation were determined for the 
specified cooling rates.  Data points on the figure correspond to conditions at which 
nucleation was observed; for example, the square marker at t = 120 min represents the 
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relative supersaturation at the instant of nucleation of paracetamol from methanol at σ = 
0.02 and nucleation temperature of 51.41 °C.  Due to slightly different dependencies of 
the solubilities on temperatures in the two solvents, saturation is reached more rapidly in 
the methanol solutions.  This can be observed by examination of the x-axis; the relative 
supersaturation curves of the methanol solutions start at a lower time than those of the 
ethanol solutions for the same cooling rate.  As a parallel to Figure 4-14, Figure 4-15 
superimposes the instances of nucleation for both solutions as represented by their 
supersaturation.  The figure, thus, appropriately demonstrates the interdependencies of 















































As an alternative we can also consider the case in which the batch process is 
carried out at an initial constant supersaturation for both solutions (Figure 4-16).  If we 
were to start the cooling of the solutions examined in this research at a relative 
supersaturation of -0.30 (i.e., the solutions are undersaturated), then the paracetamol 
solutions in ethanol are brought to saturation more quickly than are those in methanol. 
This is true for all cooling rates. In the experiments conducted, the runs were initiated at a 
constant temperature, rather than at a constant supersaturation. Accordingly, the relative 
supersaturation at the initiation of the runs involving ethanol solutions was approximately 


































Figure 4-16.  Relative supersaturation as a function of time and cooling rate for paracetamol in ethanol and 






4.4.1.2  Laminar-Flow Tubular Crystallizer System 
As with the batch experiments, the initial solution temperature was approximately 
69.5 °C.  The temperature in the jacket of the LFTC and receiving vessel was 
approximately 11.5 °C.  As mentioned earlier, the feed solutions were of concentrations 
of 34.02 g paracetamol / 100 g ethanol and 55.66 g paracetamol / 100 g methanol, using 
the same amounts of materials for batch and LFTC studies.  Studied flow rates for the 
ethanol solution were 10.8, 26.7 and 42.9 mL/min.  For the methanol solutions the 
experimental flow rates were 15.6, 30.4 and 47.2 mL/min. 
No crystals were detected, either by visual inspection or FBRM readings, leaving 
the crystallizer tube, however nucleation events were detected by the FBRM shortly after 
the cold solutions entered the receiving vessel.  For ethanol solutions the median and 
mean lengths at equilibrium were recorded as 15.02 ± 0.35 µm and 19.30 ± 0.34 µm, 
respectively, while for the methanol solutions these values were 14.71 ± 0.42 µm and 
20.31 ± 0.39 µm.  The CLD median and mean values at equilibrium remained practically 
the same regardless of the flow rate through the LFTC for the studied ethanol and 
methanol solutions.  These CLD mean and median can then be interpreted as limiting 
values for laminar-flow in these particular systems.  
Figures 4-17 and 4-18 superimpose the CLD obtained at equilibrium in LFTC 
runs and those of batch experiments.  The LFTC curve shows an increase in the counts as 
well as a shift to the smaller values of chord length, representing the presence of more 
crystals with smaller mean size.  The reported values for median and mean CLD are 
about 3 µm lower than those registered for ethanol solutions crystallized at 0.40 °C/min, 
and about 6 µm lower for those of methanol solutions under the same conditions.  This 
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difference is greater when compared to batch crystallizations at 0.15 °C/min cooling 
rates.   
As mentioned previously, due to the velocity profile and RTD of the LFTC we 
did not expect a priori a narrow distribution.  Furthermore, since no crystals were 
observed leaving the LFTC the RTD in the tubular part of the system may play an 




























Figure 4-17.  Chord length distributions at equilibrium for paracetamol crystallized from ethanol solutions 
at different batch cooling rates and through the LFTC. 
 
Solutions in the LFTC experience high supersaturations during their flow through 
the tube.  Relative supersaturations were estimated as 1.30 and 1.23 for ethanol and 
methanol solutions respectively at the outlet of the LFTC.  These values are significantly 
higher than those required for nucleation in batch operation (Fig. 4-14, Table 4-2).  The 
fact that nucleation was not observed in the LFTC can result from expansion of the 
metastable zone width or an inability to detect nuclei formed.  As higher cooling rates 
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increase the width of the metastable zone, the faster removal of heat performed by the 
LFTC due to its large surface area and low temperatures, promotes even wider metastable 
zones.  This in essence could have made the system incapable of producing crystals 




























Figure 4-18.  Chord length distributions at equilibrium for paracetamol crystallized from methanol 
solutions at different batch cooling rates and through the LFTC. 
 
By the same token these high supersaturations promoted the formation of smaller 
crystals, as we have seen, by increasing also the nucleation rate.  On average the 
nucleation rates determined for these two systems at the receiving vessel were 1.72×109 
m-3s-1 for the ethanol solutions and 3.91×109 m-3s-1 for the methanol solutions; values 
higher than their counterparts in the performed batch crystallization experiments.  As a 
mean for comparison, Figure 4-19 shows the average nucleation rates for batch 
crystallizations as columns, while comparing them to the ones obtained with the LFTC 
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system, represented by lines.  Notice that the difference in nucleation rates is more 

























Paracetamol / Ethanol (Batch)
Paracetamol / Methanol (Batch)
Paracetamol / Ethanol (LFTC)
Paracetamol / Methanol (LFTC)
 
Figure 4-19.  Comparison of nucleation rates for batch and LFTC system with paracetamol in ethanol and 
methanol solutions. 
 
The LFTC also serves as a means of accelerating the crystallization process; while 
batch crystallizations can take hours according to the desired cooling rate, crystallization 
from warm solutions in the LFTC system can be performed in a matter of minutes, 
substantially reducing run time at a larger scale.  For examples of this we can refer to 
Table 4-3.  Using the described experimental setup, a batch crystallization process of 
paracetamol / ethanol solutions would take 4.6 to 9.0 hours to reach equilibrium in the 
slurry (taking into account cooling time prior to nucleation).  Crystallization of 
paracetamol from ethanol via LFTC can crystallize and reach equilibrium in the slurry in 
a period of 30 to 40 minutes after being deposited in the receiving vessel.  Since 
paracetamol in methanol requires less supersaturation to nucleate, less amount of time is 
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required for it to crystallize and reach equilibrium than with ethanol solutions.  
Depending on the conditions, equilibrium was reached in the slurry between 2.2 and 7.4 
hours during batch operation.  It only took about 8 to 12 minutes for the solution to 
crystallize and reach equilibrium in the receiving vessel after flowing through the LFTC. 
 
 
Table 4-3.  Average time for paracetamol solutions to crystallize and reach equilibrium in the slurry. 
 
 Ethanol solutions Methanol solutions 
Batch Crystallization     
Cooling rate (°C/min)     
0.15 9.0 h 7.4 h 
0.20 6.8 h   
0.30 5.8 h 4.7 h 
0.40 4.6 h 2.2 h 
LFTC Crystallization 30 - 40 min 8 - 12 min 
 
 
4.4.1.3  Paracetamol Polymorphism 
Figure 4-20 shows a photomicrograph of crystals obtained from a methanol LFTC 
run at a flow rate of 30.4 mL/min and 11.5 °C jacket temperature.  The sample was 
obtained about 15 minutes after nucleation was detected by the FBRM.  The arrows on 
the figure point out a few of the needle-shaped (Form II) crystals that were found in this 
run.   
Powder XRD patterns (Phillips PANalytical X’Pert PRO, CuKα radiation, 1.541 
Å wavelength, see Fig. 4-21) from the product of the same run coincide with those of 
Form I.75  The sample for this pattern was vacuum-filtered and left to dry at room 
conditions for 24 hours prior to grinding and XRD analysis.  It is likely that Form II 
peaks were not detected in the powder XRD pattern in Fig. 4-21 because of the great 
difference in mass fraction of the two polymorphs.   
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Figure 4-20.  Paracetamol crystals obtained from a methanol solution through the LFTC at a 30.4 mL/min 
flow rate with 11.5 °C cooling temperature.  Arrows indicate needle-shaped (Form II) crystals.  The sample 
does not necessarily reflect the actual size distribution of the entire batch.  (Image at 10x magnification). 
 
 












Figure 4-21.  PXRD pattern of paracetamol crystallized from a methanol solution via LFTC at 30.4 
mL/min and a cooling temperature of 11.5 °C. 
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Clearly, there was simultaneous production of the two polymorphs, with Form I 
being favored.  Because the sample was obtained about 15 minutes after the instant of 
nucleation, solvent-mediated transformation of the Form II crystals might have taken 
place. 
Motivated by the presence of Form II crystals in the aforementioned LFTC 
experiments at 11.5 °C, an attempt was made to maximize the formation of these crystals 
by maintaining the LFTC at a temperature of 3 °C for a warm paracetamol / methanol 
solution to flow through.  A sample obtained shortly after crystallization, before reaching 
equilibrium, and observed through a microscope (Figure 4-22) shows the presence of 
both Forms I and II of paracetamol.  Form II crystals are small when compared to some 
of the prismatic Form I crystals present in the slurry.  This suggests that Form II crystals 
nucleated and grew to the extent that they are capable before dissolving via a solvent-
mediated transformation mechanism.  Through this mechanism, Form I crystals grow at 
the expense of the needle-shaped crystals.  Nichols and Frampton75 observed this phase 
transition in solution and studied it at different experimental conditions.   
Figure 4-23 shows another sample of material from the same 3 °C run obtained 15 
minutes after equilibrium was reached.  Although there might have been a very small 
amount of Form II crystals present, none were observed.  This verifies the presence of a 
solvent-mediated transformation mechanism.   
As suggested by Nichols and Frampton75, in order to retain the Form II 
polymorph, it is necessary to harvest the crystals shortly after the nucleation event.  The 
LFTC has shown that is capable of producing this polymorph without addition of seeds, 
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although concomitantly with Form I.  Lower operation temperatures for this crystallizer 
are suggested to further explore the possibility of nucleation of pure Form II.   
 
   
Figure 4-22.  Paracetamol crystals obtained from a methanol solution through the LFTC at a 30.4 mL/min 
flow rate with a cooling temperature of 3 °C, before reaching equilibrium.  Notice the presence of both 




Figure 4-23.  Paracetamol crystals obtained from a methanol solution through the LFTC at 30.4 mL/min 
flow rate with a cooling temperature of 3 °C, 15 minutes after reaching equilibrium.  The sample does not 
necessarily reflect the actual size distribution of the entire batch.  (Image at 10x magnification). 
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 It should be pointed out that Nichols and Frampton75 were able to obtain Form II 
from an unseeded batch experiment in an ethanol/methanol (96% / 4% vol.) solvent 
carried out at -75 °C.  In this experiment, crystallization began after 7 days.  After 21 
days at constant temperature, the researchers were able to identify the crystals as Form II.  
Conversion to Form I was verified after 43 days.  The focus of their research though was 
on seeded crystallizations, so an optimal temperature for unseeded production of Form II 
in batch crystallization was not studied by the authors.  
 The presence of Form II crystals at the 3 °C LFTC experiment, suggest that such 
an extreme low temperature is not necessary to produce these crystals through the use of 
a LFTC.  An optimal temperature in which only Form II is produced still needs to be 
researched.  
 
 4.4.2  D-mannitol 
Experiments were performed at two different concentrations; (1) 50.4 g of D-
mannitol dissolved in 200 g of water (25.2 g / 100 g water), for a saturation temperature 
of 30 °C,4 and (2) 82.8 g of D-mannitol dissolved in 175 g of water (47.3 g / 100 g water) 
with a saturation temperature estimated to be 48.4 °C by van’t Hoff interpolation of 
available data.4  Solubility data is shown in Figure 4-24.   
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Figure 4-24.  Solubility data for D-mannitol in water.  Van’t Hoff fit is shown with its regression equation 
for estimation of solubility.  (Solubility data from Mullin).4  
 
4.4.2.1  Batch Crystallization   
Batch experiments with D-mannitol were performed at four different cooling 
rates, namely 0.15, 0.20, 0.30, and 0.40 °C/min.  Initial and final temperatures for these 
two sets of runs were approximately 39 °C and 11.5 °C for those using a solution at low 
concentration and approximately 69.5 °C and 11.5 °C for those using solution at high 
concentration. 
For the low concentration batch experiments, regardless of the cooling rate, 
nucleation occurred well after the final temperature of 11.5 °C (σ = 0.75) was achieved.  
Average value of median CLD at equilibrium was 10.31 ± 0.25 µm, while the mean was 
16.27 ± 0.07 µm, regardless of cooling rate.  The paracetamol experiments discussed in 
the previous section showed a decreasing trend in size with higher cooling rates; this was 
not the case for the D-mannitol experiments where variations in mean and median CLD 
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at equilibrium were minimal.  This can be attributed mainly to the crystallization of D-
mannitol as needle-shaped crystals as seen in Figure 4-25. 
 
 
Figure 4-25.  D-mannitol crystals obtained from aqueous solution (47.3 g / 100 g water) through batch 
cooling crystallization at 0.20 °C/min.  The sample does not necessarily reflect the actual size distribution 
of the entire batch.  (Image at 10x magnification). 
 
The formation of crystals proceeded slowly, well after the final temperature was 
reached.  Due to this slow production of crystals, the counts detected by the FBRM 
experienced fluctuations during the period in which nucleation took place.  Consequently, 
the derivative of the zeroth moment showed significant noice during this time, making it 
impossible to identify a single peak that could be taken as representative of nucleation 
rate.  Instead, the linear portion of the zeroth moment plot was fitted to a linear equation, 
whose derivative (i.e. slope) represented the nucleation rate.  The estimated nucleation 
rate values from single runs performed at the specified cooling rates are summarized in 
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Table 4-4.  As shown previously, higher nucleation rates correspond to higher batch 
cooling rates. 
 
Table 4-4.  Nucleation rates for batch crystallization of D-mannitol solutions (25.2 g / 100 g water) at 










Batch experiments performed with the higher concentration solutions experienced 
nucleation while being cooled at the specific cooling rates, contrasting with those of 
lower concentration that crystallized well after the 11.5°C temperature was reached.  
Figure 4-26 shows the nucleation temperatures at the different cooling rates.  Nucleation 
started at lower temperatures with higher cooling rates, as has been shown also for the 
case of paracetamol and naproxen sodium in Chapter 3.   
Nucleation temperature can also be expressed in terms of the metastable zone 
width for the particular conditions, as seen in Table 4-5.  Higher cooling rates can be 





























Figure 4-26.  Average nucleation temperatures for D-mannitol crystallized from aqueous solutions (47.3 g 




Table 4-5.  Average values of nucleation temperature, metastable zone width and relative supersaturation 
at nucleation according to cooling rate for the cooling batch crystallization of D-mannitol from aqueous 














0.15 35.44 12.92 0.47 
0.20 33.51 14.85 0.57 
0.30 31.30 17.06 0.68 
0.40 27.75 20.61 0.88 
 
Based on nucleation temperature and solubility data, relative supersaturation at 
nucleation was calculated for the different cooling rates, as shown in Figure 4-27 and 
Table 4-5.  The figure describes the trend that we have already observed; higher 
nucleation temperatures would reflect into higher equilibrium concentrations, henceforth 
smaller differences between actual concentration and equilibrium concentrations, 
rendering smaller values of relative supersaturation.  For this reason we see how the 
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relative supersaturation required for nucleation is directly proportional to the cooling rate.  
Choosing a linear fit for the data shown in Figure 4-28 shows us that the relative 
supersaturation required to achieve nucleation at an infinitesimal cooling rate is close to 



































Figure 4-27.  Relative supersaturation at nucleation for the crystallization of D-mannitol from aqueous 
solutions (47.3 g / 100 g water). 
 
Figure 4-28 give us an idea of the relative supersaturation that the solutions 
experience through time at the different cooling rates.  Supersaturation is achieved in less 
amount of time at higher cooling rates.  As with paracetamol, higher cooling rates would 
promote nucleation earlier (in terms of process duration), albeit at a higher 































Figure 4-28.  Relative supersaturation as a function of time and cooling rate for D-mannitol aqueous 
solutions (47.3 g / 100 g water). 
 
Figure 4-29 shows the determined nucleation rates for D-mannitol for the high 
concentration batch experiments.  As expected, higher cooling rates promoted higher 
rates of nucleation.  The effect of higher concentrations decreasing the metastable zone 
width was also reflected on the nucleation rates.  The values obtained ranged from 
2.09×109 to 3.04×109 m-3s-1, almost an order of magnitude higher than the batch 
experiments at low concentration.   
Median and mean values for the CLD suffered from the same effects related to 
crystal morphology; average values were 8.77 ± 0.27 µm and 15.97 ± 1.10, respectively, 
regardless of cooling rate.  Due to the morphology of the crystals, a relationship between 


























Figure 4-29.  Nucleation rates determined by zeroth moment analysis for D-mannitol crystallized from 
aqueous solutions (47.3 g / 100 g water). 
 
4.4.2.2  Laminar-Flow Tubular Crystallizer System 
LFTC experiments were performed with the same amount of materials and at the 
same concentrations than batch experiments, namely 25.2 g / 100 g water and 47.3 g / 
100 g water.  Low concentration experiments had a temperature setpoint on the solution 
vessel of 40 °C, while pumped through the LFTC at a setpoint of 10 °C.††  Experiments at 
the higher concentration had warm solution temperatures of 69.5 °C, and were pumped 
through the LFTC at temperature setpoints of 10 °C, 20 °C, 30 °C, and 40 °C.  Studied 
volumetric flow rates for all D-mannitol LFTC experiments were 11.9, 28.2 and 45.5 
mL/min.   
                                                 
†† Throughout this section of the text references will be made about the temperature setpoints in the system.  
Due to heat interaction with the surroundings, the actual temperatures were slightly different.  These can be 
averaged as follows:  for a setpoint of 10°C, the corresponding temperature was 11.5°C; for a setpoint of 
20°C, it was 21°C; for 30°C, it remained the same, and for 40°C, it was closer to 39°C.  Calculations 
regarding concentration and supersaturation were performed with the actual temperatures in mind, although 
reference might be made to the setpoints. 
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Run times in the low-concentration LFTC experiments with D-mannitol were 
comparable to those in batch mode; nucleation occurred hours after the solution was 
transferred into the receiving vessel.  The rate of formation of crystals was slow, and the 
determination of nucleation rates had to be carried out by linear-fit analysis, as was done 
with the low-concentration batch runs.  The nucleation rates were 3.95×108 m-3s-1 for a 
single run at 11.9 mL/min, 2.88×108 m-3s-1 (average value of three runs) for 28.2 mL/min, 
and 5.20×108 m-3s-1 for a single run at 45.5 mL/min.  Although the nucleation rate varied, 
it did not do so following any particular trend.  This is likely due to the extended period 
of time (4 to 6.4 hours) that the solution remained in the receiving vessel before 
nucleation, compared to the time it spent flowing through the LFTC (mean residence time 
ranging from 20.34 to 76.05 seconds).  This prolonged period before the nucleation event 
is registered by the FBRM is reason to believe that no D-mannitol nuclei formed in the 
LFTC. 
Median and mean values of the CLD were also similar to other experiments, 
independent of the flow rate, 8.33 ± 0.40 µm and 15.00 ± 1.10 µm, respectively.  This 
similarity in median and mean values with other experiments can be attributed again to 
the needle morphology of the crystals. 
LFTC experiments at the higher concentration focused in studying patterns related 
to both flow rate and low temperature set point.  As with the other cases studied in this 
chapter, crystallization of D-mannitol in the high concentration LFTC experiments 
occurred inside the receiving vessel.  Crystallization took place in a matter of minutes, 
with lower temperatures favoring earlier nucleation events.  Nucleation started in less 
than 5 minutes after the solution got transferred into the receiver for the low temperature 
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setpoint of 10 °C.  This increased to about 8 minutes for the 20 °C setpoint, to about 13 
minutes for the 30 °C setpoint, and finally to 40 minutes for the 40 °C setpoint.  This 
prolonged time for the 40 °C run again resulted from slow formation of crystals, which is 
why the nucleation rate was determined by linear-fit analysis for these runs. 
 Figure 4-30 shows the determined nucleation rates for these runs according to the 
different temperature set points of the LFTC and receiving vessel jackets.  Flow rate, as 
with the case of paracetamol, did not affect the rate of nucleation.  Lower cooling 
temperatures (and hence higher supersaturations) promoted higher nucleation rates.  This 
relationship is summarized in Table 4-6 in terms of relative supersaturation.  A 
significant difference is observed between the relative supersaturation achieved according 
to cooling temperature.‡‡  Also, most significant is the difference observed in nucleation 
rate at 40 °C, which was an order of magnitude lower than determined at the lower 
temperatures.   
There was no great change detected in terms of CLD size for the runs with the   
10 °C, 20 °C, and 30 °C setpoints, or with change in flow rate.  In average, the recorded 
values of the CLD were 8.24 ± 0.52 µm for the median and 18.66 ± 3.01 µm for the 
mean. 
D-mannitol did not prove to be an appropriate crystalline system to study in terms 
of CLD due to its needle morphology.  Nonetheless, the data acquired gave us more 
insight about the role of supersaturation, metastable zones and nucleation rates.  
Nucleation rates for the high concentration solution in the LFTC system ranged from 
9.36×109 to 1.08×1010 m-3s-1 (with the exception of the 40 °C runs) surpassing those of 
                                                 
‡‡ The progression of the relative supersaturation through the LFTC can be seen in Appendix C, where D-
mannitol solutions are used as model examples. 
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batch operation for solutions of the same concentration, reaching the value of 3.04×109 
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Figure 4-30.  Nucleation rates as determined by zeroth moment analysis for crystallization of D-mannitol 
from aqueous solutions (47.3 g / 100 g water) at different temperatures on the LFTC. 
 
 
Table 4-6.  Approximate relative supersaturation at the outlet of the LFTC and average nucleation rates in 














10 11.5 2.29 1.08×1010 
20 21 1.36 1.04×1010 
30 30 0.75 9.36×109 
40 39 0.32 9.45×108 
 
Table 4-7 summarizes the time necessary to reach equilibrium of the slurry after 
nucleation and growth of D-mannitol from the studied 47.3 g / 100 g water solutions.  As 
we emphasized with paracetamol, the time to reach equilibrium is significantly decreased 
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in LFTC operations than in batch crystallizations.  Ultimately this is one of the greatest 
assets of the LFTC, pending on the desire to obtain crystals of smaller mean size. 
 
Table 4-7.  Average time for D-mannitol solutions (47.3 g / 100 g water) to crystallize and reach 
equilibrium in the slurry.  For solutions of 25.2 g / 100 g water, the time to crystallize and reach 
equilibrium was approximately 8.5 hours, both in batch and LFTC modes.  
 
Batch Crystallization Time 
Cooling rate (°C/min)   
0.15 6.0 h 
0.20 4.7 h 
0.30 3.6 h 
0.40 2.6 h 
LFTC Crystallization   
Low Temperature Setpoint 
(°C)   
10    8 min 
20 10 min 
30 20 min 
40 95 min 
 
 












Figure 4-31.  PXRD pattern of D-mannitol crystallized from an aqueous solution via LFTC. 
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Powder XRD spectra of recovered samples showed that the crystallized form 
obtained was the β polymorph (Fig. 4-31) when compared to published data.22, 86, 88  
Experiments with other solvents might prove useful in obtaining α and δ forms of D-
mannitol, as suggested by the literature.22, 86, 88 
 
4.5 Conclusions 
The experiments described in this chapter demonstrated that the LFTC was able to 
produce crystals with a smaller mean size than could be produced in the corresponding 
batch cooling crystallization.  This conclusion is based on measured chord-length 
distributions obtained by a focused beam reflectance measurement (FRBM) device 
positioned to provide such data throughout each experiment.  The effect of the two 
different crystallizer configurations on mean crystal size was especially noticeable when 
the solute was paracetamol.  Precise analyses of the D-mannitol chord-length 
distributions obtained by the FBRM were made difficult by the needle-like crystal shape 
produced with this solute. 
In addition to comparisons between the two crystallizer configurations, variations 
with specific process variables within each crystallizer type were also investigated.  For 
example, the mean size of paracetamol crystals produced in batch crystallizations was 
reduced with increasing cooling rates.  Also, higher nucleation rates corresponded to 
higher supersaturations generated by the LFTC, as seen from D-mannitol experiments.   
The batch crystallization system was used to evaluate the metastable limits and 
the corresponding metastable zones for both paracetamol and D-mannitol.  As cooling 
rates increased, the metastable zone width and nucleation rates increased.  The increases 
in nucleation rates led to reductions in mean crystal size. 
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The research described in this chapter highlighted two possible advantages of the 
LFTC, in addition to the production of finer crystals.  First, because cooling occurred so 
rapidly and the resulting crystal mass grew faster because of the greater crystal surface 
area, the operating time required to go from initial to final conditions could be 
dramatically reduced.  Clearly the higher heat-transfer coefficients associated with forced 
convection contribute to this advantage.  Of course, if large crystals are essential in the 
product specifications, the advantage of reduced operated time is overwhelmed by the 
disadvantage of producing smaller crystals.  
Second, the data on paracetamol clearly show that it is possible to produce an 
unstable polymorph because of the exceedingly high rate at which supersaturation is 
generated.  The possibility of extending such behavior to other systems must be evaluated 











EXPERIMENTAL SOLUBILITY DATA FOR NAPROXEN SODIUM IN WATER 
 
 
 Temperature Concentration 
 (°C) (g anhydrate / kg solution) 
Dihydrate 15.2 ± 0.16 104.3 
 17.3 ± 0.27 121.5 
 20.0 ± 0.11 145.5 
 22.9 ± 0.26 181.2 
 26.6 ± 0.24 223.7 
 27.9 ± 0.13 240.2 
 28.3 ± 0.13 246.1 
Anhydrate 30.3 ± 0.15 273.7 
 34.1 ± 0.23 308.1 
 36.9 ± 0.17 333.7 











OTHER SYSTEMS STUDIED IN BATCH AND LAMINAR-FLOW TUBULAR 
CRYSTALLIZERS 
 
 The purpose of this appendix is to summarize some of the materials used in 
experiments that proved to be ineffective for different reasons.  In some instances this 
was due to low FBRM readings attributed to low solids concentration, in others because 
crystallization occurred inside the laminar-flow tubular crystallizer (LFTC) at a rate that 
caused clogging of the material inside it.  The latter proved to be rather problematic for 
the unclogging part. 
 
Glycine (98%, Acros Organics) 
 Most of the experiments with glycine were performed on aqueous solutions with 
23.10 g in 100 g of water (saturation temperature of 30 °C) cooled to a 10 °C set point.  
Crystallization did not occur in the LFTC.  Both batch and LFTC experiments 
experienced low counts in the FBRM (from 15 to 70) which could have been easily 
affected by background readings.  A batch experiment with a concentration of 38.49 g / 
100 g water was performed, and although counts reached values up to 210, the data was 
unreliable due to the multiple peaks in the CLD and the variation of readings in different 




L-glutamic acid (99%, Acros Organics) 
 The low solubility of this material in water, 1.21 g / 100 g water at 30 °C, 
rendered it inappropriate for CLD characterization via FBRM.  The material did not 
crystallize in the LFTC. 
 
L-serine (Ajinomoto U.S.A., Inc.) 
 A batch experiment with a concentration of 35.05 g / 100 g water (Tsat = 50 °C) 
was performed having FBRM counts up to 70, clearly influenced by background readings 
due to multiple peaks detected. 
 
Naproxen sodium (Albermale Corp.) 
 One experiment was performed on the LFTC with 64.32 g of naproxen sodium 
dissolved in water (Tsat = 30 °C).  Temperature was set to 45 °C on the solution vessel, 
and to 20 °C on the LFTC and receiver vessel.  Crystallization did not occur on the 
LFTC.  Another run was then performed with the low temperature set at 10 °C.  This 
promoted the formation of slurry which proceeded to clog the LFTC. 
 
Oxalic acid dihydrate (Certified A.C.S., Fisher Scientific)   
 Experiments performed with the LFTC with 21.55 g dissolved in 100 mL of water 
would often clog the crystallizer when cooled from setpoints of 45 °C to 10 °C.  For these 
same concentration and temperature conditions, batch experiments rendered very low 
FBRM counts (below 30). 
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Potash alum (Certified A.C.S., Fisher Scientific) 
 Experiments were performed on the LFTC with 32.80 g of potash alum dissolved 
in 200 g of water (Tsat = 30 °C) and with 63.04 g dissolved in 175 g of water (Tsat =       
50 °C).  The first ones had a 45 °C setpoint on the solution vessel and cooled to 20 °C 
and 10 °C, while the latter ones had a 73 °C setpoint on the solution vessel and cooled to 
10 °C, 20 °C, and 40 °C.  None of the experiments experienced crystallization on the 
LFTC.  Crystallization occurred in a matter of minutes on the receiving vessel with low 
counts (less than 65), multiple peaks in the CLD and variation in the different chord 
length channels.  
 
Sodium sulfate anhydrate (Certified A.C.S., Fisher Scientific) 
 Sodium sulfate exhibits inverse solubility over temperatures near 40 °C.  For this 
reason, one experiment was performed on the LFTC with saturation temperature 
conditions of 30 °C, dissolving 71.4 g in 175 g of water.  The setpoint on the circulator 
for the solution vessel was 41°C, and for the LFTC and receiver 10 °C.  Crystals were not 
observed or detected by the FBRM even after two and a half hours in the receiving 
vessel.  When the lower valve of the receiving vessel was open to remove the solution, a 
gel-like substance was recovered. 
 
Succinic acid (99%, Acros Organics) 
 An experiment was performed on the LFTC with 49.20 g dissolved in 200 g of 
water (Tsat = 50 °C).  For this experiment the temperature was set to 73 °C for the 
solution vessel and to 40 °C on the LFTC and receiver.  The material crystallized 
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clogging the LFTC.  Experiments at a lower solubility, dissolving 21.21 g in 200 g of 
water (Tsat = 30 °C) and with temperature setpoints of 45 °C for the solution vessel and 
















TEMPERATURE AND SUPERSATURATION PROGRESSIONS IN THE 
LAMINAR-FLOW TUBULAR CRYSTALLIZER 
 
C.1  Introduction 
Characterization of the laminar-flow tubular crystallizer (LFTC) involves, among 
other things, the fundamental knowledge of heat transport.  Temperature distribution 
along the length of the crystallizer is useful to understand contact time of the solution at a 
specific temperature.  Such information proves useful in determining the supersaturation 
in which a solution is exposed while being transported throughout the crystallizer. 
As described in Chapter 4, the LFTC is composed of a 7.62 m long PTFE tube 
(1.5875 mm ID, 3.175 mm OD) transporting the solution, surrounded by another PTFE 
tube (11.11 mm ID, 12.70 mm OD) with water on counterflow as the cooling fluid. 
Three different models were used to describe the heat transfer characteristics of 
the system.  Fully developed thermal and hydrodynamic flows were assumed where 
necessary.  The entrance regions for these flows were estimated for the studied flow rates, 
ranging from 10.8 to 47.2 mL/min, and determined negligible when compared to the 
entire length of the LFTC.   
It was not possible to measure all the required properties of the solutions at 
different temperatures to do this according to the studied systems.  For this reason the 
analyses focus on the use of a specific solvent to characterize heat transfer.  Specifically, 
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water (the solvent in D-mannitol experiments) is used for these models based on actual 
experimental conditions.  
 Since crystallization did not occur inside the LFTC in the cases discussed in 
chapter 4, heat of crystallization was not brought into the analyses.  Heat losses or 
additions from the environment were neglected throughout the LFTC length.  For this 
purpose, the LFTC was covered by two layers of 0.95 cm thick elastomeric foam wrap.  
Since the solution is transported for a short distance between the solution vessel, the 
pump and the LFTC, heat losses were experienced.  Due to this, the reader will notice in 
the analyses that the temperature at the inlet of the tube varies from run to run.  
Generally, a run at a lower flow rate would loose more heat than one at a higher flow rate 
due to the increase in residence time and longer exposition to ambient conditions at non-
isolated sections of the tubing.  
Axial conduction was neglected on the basis of high Péclet numbers Pe = Re Pr 
( >~ 100).94  The reader will notice that the LFTC is hereon treated as a concentric double-
pipe heat exchanger for the sake of the discussion. 
 
C.2  Number of Transfer Units (NTU) method for heat and outlet temperature 
determination 
 For this model, a constant wall temperature along the length of the LFTC was 
assumed.  In reality the difference between the inlet and outlet temperatures of the outer 
tube was rarely over 1 °C.  For the purpose of the method, the wall temperature was 
estimated as the geometrical average of inlet and outlet temperatures of the outer tube.  
Water properties, namely heat capacity Cp, thermal conductivity k, density ρ and 
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viscosity µ, were calculated at the inlet temperature of the solution.  The Fanning friction 
factor f for each flow rate was calculated from: 





=                                                            (C.1) 
The Nusselt NuD number was assumed at a constant value of 3.66 for the system, 
based on constant wall temperature and tube flow.  From this, the heat transfer coefficient 
h was calculated from: 
                                                             
k
hDNuD =                                                         (C.2) 
The overall NTU’s were calculated from: 










==                                               (C.3) 
And the efficiency ε of the “heat exchanger” as: 
                                                       )exp(1 NTU−−=ε                                                 (C.4) 
Due to the large surface area of the entire LFTC, the NTU values were relatively high, 
rendering an efficiency of 1.  This means that the total heat lost by the warm solution will 
be the same as the maximum heat that it is possible for it to loose (q = qmax ε).  From the 
heat equation, the heat transferred was calculated: 
                                                             TCmq p∆= &                                                       (C.5) 
where, for this case ∆T stands for the difference between wall and inlet temperature of the 
solution.  The model, having a perfect efficiency, estimates the outlet temperature of 
solution to be that of the wall temperature.  Notice that since the model assumes a value 
for the constant wall temperature, the result of the model will be biased accordingly, i.e. 
the outlet temperature of the solution will be the same as the average wall temperature 
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specified for the model.  Table C-1 summarizes the results for different flow rates and 
temperatures. 
 
Table C-1.  Data and calculated values for heat transfer on the LFTC by NTU method with constant wall 
temperature.  Inlet and outlet temperatures are experimental data values.  Notice that the values on the first 
column are the setpoints of the thermobath circulators, and not the actual measured values. 
 
Temperature Flowrates Crystallizer Crystallizer Cooling Cooling Average Fanning Heat Expected
setpoints (mL/min) inlet outlet fluid inlet fluid outlet wall friction exchanged crystallizer outlet
temperature (°C) temperature (°C) temperature (°C) temperature (°C) tempeture (°C) factor (W) temperature (°C)
11.9 59.85 10.93 10.44 10.81 10.63 0.05 40.13 10.63
73 - 10°C 28.2 62.64 10.97 10.40 11.39 10.90 0.02 99.81 10.90
44.5 65.24 13.04 10.50 12.18 11.34 0.01 163.85 11.34
11.9 59.56 20.45 20.28 20.61 20.45 0.05 31.89 20.45
73 - 20°C 28.2 63.47 20.83 20.37 21.22 20.80 0.02 82.27 20.80
44.5 64.36 22.10 20.26 21.53 20.90 0.01 132.17 20.90
11.9 60.04 30.10 30.18 30.37 30.28 0.05 24.26 30.28
73 - 30°C 28.2 62.80 30.27 30.18 30.69 30.44 0.02 62.42 30.44
44.5 63.38 31.43 30.19 31.08 30.64 0.01 99.63 30.64
11.9 59.00 39.68 40.10 40.11 40.11 0.05 15.41 40.11
73 - 40°C 28.2 62.96 39.98 40.09 40.39 40.24 0.02 43.82 40.24
44.5 63.48 40.71 40.13 40.71 40.42 0.01 70.16 40.42  
 
 
C.3  NTU method for temperature progression along the inner tube with given inlet 
and outlet temperatures 
 Since inlet and outlet temperatures of the solution are known from the data 
acquisition, they can be utilized along the properties of water to look at the progression of 
temperature along the length of the inner tube, assuming also constant wall temperature.  
Using the local number of transfer units NTUx, 




















πexp1)exp(1                            (C.6) 
the bulk temperature Tbulk can be solved along the length of the LFTC.  Notice that the 
model does not use wall temperature as a parameter.  Figure C-1 shows the progression 






























































































Figure C-1.  Temperature progression of the solution along the length of the LFTC assuming constant wall 
temperature for different temperature setpoints. 
 
C.4  Finite differences analysis for temperature progression 
 A method based on that explained by Holman95 was developed.  The method 
takes small finite elements of the LFTC for analysis based on temperature conditions at 
one end of the node to then determine the temperatures at the other end.  This permits the 
estimation of the temperature progressions of both inner and outer tube with better 
accuracy than the previous models.  The model also takes advantage of the temperature 
dependency of the properties of the solvent.  The model was built on a parallel flow 
presumption and then solved for countercurrent conditions on a spreadsheet.  The 
procedure for it is as follows: 
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1. A characteristic length of 0.02 m was chosen, and therefore a characteristic 
surface area of 9.97×10-5 m2. 
2. The heat transfer coefficients h for both solution and cooling fluid are determined 
for the characteristic length according to the temperature conditions.  In order to 
do so, we need: 
a. Inlet temperature of the solution and outlet temperature of the cooling 
fluid (since it is countercurrent).  Outlet temperature of the cooling fluid 
can be estimated, since it is going to be determined later on. 
b. Determine the thermal conductivity of water at the given temperature 
conditions for both the solution and the cooling fluid. 
c. Assume constant Nusselt number values; 3.66 for the solution inside the 
tube (since we are assuming constant wall temperature along the selected 
characteristic length), and 7.11 for the cooling fluid based on the annular 
ratio Di/Do (as estimated from data by Thomas,94 where Di stands for the 
outer diameter of the inner tube, and Do is the inner diameter of the outer 
tube). 
d. Calculate h for solution (hi) and cooling fluid (ho) from equation C.2.  An 
equivalent diameter De of 0.03563 m was calculated for the outer tube as 
























π              (C.7) 
where rh is the hydraulic radius, D1 is the outer diameter of the inner tube, 
and D2 is the inner diameter of the outer tube. 
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3. The thermal conductivity k (in W/m °C) of PTFE (the tube material) is calculated 
from the geometrical average of the solution and cooling fluid temperatures (in 
°C) from97: 
                                                     253.0000486.0 += Tk                                              (C.8) 
4. With the h and k values, the overall heat transfer coefficient for the solution Ui is 
calculated as: 















1                                     (C.9) 
where the subscripts i and o refer to the inside and outside of the inner tube 
respectively, and A is the cross-sectional area. 
5. The incremental heat transfer ∆qj for the specific incremental area ∆Aj can then be 
calculated as: 
                                                 joijjij TTAUq )( −∆=∆                                        (C.10) 
6. With the values of mass flow rate m& and heat capacity Cp evaluated at the known 
temperatures for both solution and cooling fluid§§, the temperatures of both flows 
at the other side of the node can be calculated from: 
                         )()()()( 11 ++ −=−−=∆ jojojopojijijipij TTCmTTCmq &&                 (C.11) 
7. Using the newly acquired temperatures, the process is repeated for the next 
increment.   
8. Finally, when the spreadsheet has been developed for the entire length of the 
crystallizer, the temperature at the inlet of the outer tube is set, and the 
                                                 
§§ Flow rate for the cooling fluid was measured as 1.27 L/min. 
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spreadsheet is then set to solve the equations for the given conditions in 
countercurrent flow.  
 
The above procedure will render the temperature progression for both solution 
and cooling fluid in the crystallizer given the inlet temperature conditions and flow rates.  
While it is much more accurate than the previous models, there is a certain level of error, 
due to idealities in the calculations, such as properties of the solution and the assumption 
that the flow is fully developed both thermally and hydrodynamically during the entire 
length of the LFTC.  The model predicted outlet temperatures for the crystallizer with an 
average error of 3%, and outlet temperatures for the cooling fluid with an average error of 
1.4%.  Figures C-2 to C-5 show the temperature progression for solution and cooling 
fluid for different flow rates and temperatures.  In all events, higher flow rates would not 
permit the solution to reach the inlet temperature of the outer tube cooling fluid. 
Using the differential volume of the nodes chosen, each of a length of 0.02 m, an 
equivalent cooling rate for the solution was calculated for all cases.  Table C-2 
summarizes the values of these cooling rates for the inlet and outlet regions of the LFTC 
at different conditions.  Notice that for the flow rate of 11.9 mL/min, the cooling rate 
reaches zero (in reality, the calculations showed values on the order of 10-5 and 10-6 























Cooling fluid for 11.9 mL/min solution
Solution 28.2 mL/min
Cooling fluid for 28.2 mL/min solution
Solution 44.5 mL/min
Cooling fluid for 44.5 mL/min solution
 
Figure C-2.  Temperature progression for solution and cooling fluid in counterflow using finite differences 






















Cooling fluid for 11.9 mL/min solution
Solution 28.2 mL/min
Cooling fluid for 28.2 mL/min solution
Solution 44.5 mL/min
Cooling fluid for 44.5 mL/min solution
 
Figure C-3.  Temperature progression for solution and cooling fluid in counterflow using finite differences 





















Cooling fluid for 11.9 mL/min solution
Solution 28 .2 mL/min
Cooling fluid for 28.2 mL/min solution
Solution 44.5 mL/min
Cooling fluid for 44.5 mL/min solution
 
Figure C-4.  Temperature progression for solution and cooling fluid in counterflow using finite differences 



















Cooling fluid for 11.9 mL/min solution
Solution 28.2 mL/min
Cooling fluid for 28.2 mL/min solution
Solution 44.5 mL/min
Cooling fluid for 44.5 mL/min solution
 
Figure C-5.  Temperature progression for solution and cooling fluid in counterflow using finite differences 
method for 40 °C temperature setpoint. 
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  11.9 635 0 
73 - 10 °C 28.2 666 0.9 
  44.5 691 11 
  11.9 516 0 
73 - 20 °C 28.2 562 0.6 
  44.5 569 8 
  11.9 400 0 
73 - 30 °C 28.2 433 0.4 
  44.5 435 5 
  11.9 257 0 
73 - 40 °C 28.2 308 0.2 
  44.5 311 4 
 
 
C.5  Overall heat transfer coefficient 
 
 Based on the entire length of the LFTC and average temperatures, overall heat 
transfer coefficients were calculated from equation C.9.  Table C-3 summarizes the 
results. 
 






Overall heat transfer 
coefficient, U (W/m^2 °C) 
  11.9 354 
73 - 10 °C 28.2 354 
  44.5 355 
  11.9 363 
73 - 20 °C 28.2 363 
  44.5 364 
  11.9 371 
73 - 30 °C 28.2 371 
  44.5 372 
  11.9 378 
73 - 40 °C 28.2 378 




C.6  Supersaturation progression in the LFTC 
 
 The progression of relative supersaturation throughout the LFTC for a solution 
can be easily determined once the temperature of the fluid is known. Following the heat 
transfer model discussed in section C.4, the relative supersaturation of the solution was 
determined for the entire length of the crystallizer.  Figures C-6 through C-9 depict 
relative supersaturation for D-mannitol aqueous solutions through the LFTC.  Lower 
temperatures allow higher supersaturations.  Slower flow rates allow the solution to reach 
a constant supersaturation at a shorter length than at faster rates.  Table C-4 shows the 
specific distance in which supersaturation is reached.  If a specific supersaturation is 
required for a given process, it is then a matter of determining the flow rate, length or 











































































































































  11.9 0.14 
73 °C to 10 °C 28.2 0.36 
  44.5 0.65 
  11.9 0.16 
73 °C to 20 °C 28.2 0.48 
  44.5 0.80 
  11.9 0.22 
73 °C to 30 °C 28.2 0.64 
  44.5 1.04 
  11.9 0.36 
73 °C to 40 °C 28.2 1.08 










C.7  Closing remarks 
 
Of the three heat transfer models shown, the finite differences method proves to 
be the most practical tool for analysis.  Indeed, it is worth the effort of developing an 
accurate spreadsheet to calculate heat transfer parameters.  The method though is not 
flawless.  It has been mentioned that water properties were assumed for the development 
of the model, as well as the assumptions of fully developed thermal and hydrodynamic 
flows.  Calculation of the heat transfer coefficients require great care since their values 
are directly linked to Nusselt numbers based on correlations.  The equivalent diameter 
chosen for the circular annulus formed by the cooling fluid is also important, as different 
authors suggest different values, or as it can be easily miscalculated by the person 
developing the model.  The accuracy of the model though is proven when compared to 
the experimental temperature data.  Furthermore, in contrast with the NTU model 
assuming constant wall temperature, it gives a more realistic progression of temperature, 
giving the researcher a better idea of the instant in which the solution reaches the desired 
temperature.  Due to the constant wall temperature assumption, the NTU method fails to 
do this appropriately, by showing how a constant temperature is reached at the early 
stages of the LFTC, which is inaccurate, especially at higher flow rates. 
 The finite difference method gives the researcher the advantage of knowing a 
priori an accurate temperature progression, so that the decision of flow rate, crystallizer 
length, and desired final temperature and supersaturation, can be done relatively easy.   








TABULATED DATA AND RESULTS FOR THE CRYSTALLIZATION OF 
PARACETAMOL AND D-MANNITOL IN BATCH AND LAMINAR-
FLOW TUBULAR CRYSTALLIZERS 
 
D.1 Paracetamol data 
 
Solution:  Paracetamol / Ethanol (34.02 g / 100 g solvent) 
 




Cooling rate (°C/min) Nucleation temperature (°C) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
0.15 33.65 9.91E+08 25.34 29.59
0.15 36.51 9.28E+08 25.7 30.14
0.15 36.78 1.07E+09 23.27 28.22
0.15 35.61 9.44E+08 24.17 28.96
0.20 34.44 9.10E+08 24.6 28.76
0.20 35.19 1.07E+09 24.91 29.25
0.30 35.01 1.38E+09 22.42 26.92
0.30 33.10 1.47E+09 22.37 26.78
0.30 26.00 1.28E+09 21.71 25.97
0.40 29.65 1.68E+09 18.53 22.87




Cooling rate Nucleation  Standard Nucleation Standard Median   Standard Mean Standard
(°C/min) temperature (°C) deviation (°C) rate (m-3s-1) deviation (m-3s-1) (µm) deviation (µm)  (µm) deviation (µm)
0.15 35.64 1.42 9.83E+08 6.37E+07 24.62 1.11 29.23 0.83
0.20 34.82 0.53 9.90E+08 1.13E+08 24.76 0.22 29.01 0.35
0.30 31.37 4.75 1.38E+09 9.50E+07 22.17 0.40 26.56 0.51




Solution:  Paracetamol / Methanol (55.66 g / 100 g solvent) 
 





Cooling rate (°C/min) Nucleation temperature (°C) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
0.15 51.41 3.78E+08 22.43 29.35
0.15 51.41 6.46E+08 22.58 29.53
0.30 50.53 8.83E+08 20.42 27.11
0.30 48.36 1.73E+09 20.52 26.3
0.40 37.2 2.19E+09 19.93 25.6




Cooling rate Nucleation  Standard Nucleation Standard Median   Standard Mean Standard
(°C/min) temperature (°C) deviation (°C) rate (m-3s-1) deviation (m-3s-1) (µm) deviation (µm)  (µm) deviation (µm)
0.15 51.41 0.00 5.12E+08 1.90E+08 22.51 0.11 29.44 0.13
0.30 49.45 1.53 1.31E+09 5.99E+08 20.47 0.07 26.71 0.57




Solution:  Paracetamol / Ethanol (34.02 g / 100 g solvent) 
 




Flow rate (mL/min) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
10.8 1.72E+09 15.15 19.47
26.7 1.62E+09 14.61 18.86
26.7 1.61E+09 15.44 19.61
42.9 1.83E+09 14.71 19.00




Flow rate  Nucleation Standard Median   Standard Mean Standard
(mL/min) rate (m-3s-1) deviation (m-3s-1) (µm) deviation (µm)  (µm) deviation (µm)




Solution:  Paracetamol / Methanol (55.66 g / 100 g solvent) 
 




Flow rate (mL/min) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
15.6 3.96E+09 15.13 20.70
30.4 3.97E+09 14.30 19.92







Flow rate  Nucleation Standard Median   Standard Mean Standard
(mL/min) rate (m-3s-1) deviation (m-3s-1) (µm) deviation (µm)  (µm) deviation (µm)




D.2  D-mannitol data 
 
Solution:  D-mannitol / Water  (25.2 g / 100 g solvent) 
 




Cooling rate (°C/min) Nucleation temperature (°C) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
0.15 At final temperature, approx. 11.5 °C 4.05E+08 10.02 16.26
0.30 At final temperature, approx. 11.5 °C 4.45E+08 10.43 16.34





Cooling  Median   Standard Mean Standard
rate (°C/min) (µm) deviation (µm)  (µm) deviation (µm)




Solution:  D-mannitol / Water  (47.3 g / 100 g solvent) 
 




Cooling rate (°C/min) Nucleation temperature (°C) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
0.15 35.71 2.12E+09 8.82 16.19
0.15 35.17 2.05E+09 8.95 17.14
0.20 33.00 2.50E+09 8.98 16.11
0.20 35.14 2.09E+09 8.77 15.16
0.20 32.38 2.23E+09 9.20 17.45
0.30 31.56 3.02E+09 8.34 17.00
0.30 31.03 2.72E+09 8.56 15.15
0.40 26.88 3.40E+09 8.46 14.19








Cooling rate Nucleation  Standard Nucleation Standard 
(°C/min) temperature (°C) deviation (°C) rate (m-3s-1) deviation (m-3s-1)
0.15 35.44 0.38 2.09E+09 4.95E+07
0.20 33.51 1.45 2.27E+09 2.08E+08
0.30 31.30 0.37 2.87E+09 2.12E+08
0.40 27.75 1.23 3.04E+09 5.16E+08  
 
Cooling  Median   Standard Mean Standard
rate (°C/min) (µm) deviation (µm)  (µm) deviation (µm)




Solution:  D-mannitol / Water (25.2 g / 100 g solvent) 
 




Flow rate (mL/min) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
11.9 3.95E+08 8.21 14.02
28.2 3.19E+08 8.35 15.52
28.2 3.00E+08 8.81 16.55
28.2 2.44E+08 8.55 14.97




Flow rate  Nucleation Standard 
(mL/min) rate (m-3s-1) deviation (m-3s-1)
11.9 3.95E+08
28.2 2.88E+08 3.90E+07
45.5 5.20E+08  
 
Flow rate Median   Standard Mean Standard
(mL/min) (µm) deviation (µm)  (µm) deviation (µm)













Solution:  D-mannitol / Water  (47.3 g / 100 g solvent) 
 
Crystallizer:  LFTC 
 
Experimental values (73 °C – 10 °C) 
 
Flow rate (mL/min) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
11.9 1.21E+10 8.09 21.04
28.2 1.02E+10 8.51 21.87
28.2 1.01E+10 8.00 24.09  
 
Average values (73 °C – 10 °C) 
 
Flow rate  Nucleation Standard Median   Standard Mean Standard
(mL/min) rate (m-3s-1) deviation (m-3s-1) (µm) deviation (µm)  (µm) deviation (µm)
All 1.08E+10 1.13E+09 8.20 0.27 22.33 1.58  
 
 
Experimental values (73 °C – 20 °C) 
 
Flow rate (mL/min) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
11.9 1.10E+10 7.5 18.22
28.2 9.57E+09 8.19 19.77
28.2 1.13E+10 7.92 19.21
45.5 9.89E+09 7.62 18.98  
 
Average values (73 °C – 20 °C) 
 
Flow rate  Nucleation Standard Median   Standard Mean Standard
(mL/min) rate (m-3s-1) deviation (m-3s-1) (µm) deviation (µm)  (µm) deviation (µm)
All 1.04E+10 8.39E+08 7.81 0.31 19.05 0.64  
 
 
Experimental values (73 °C – 30 °C) 
 
Flow rate (mL/min) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
11.9 8.55E+09 8.56 14.31
28.2 8.72E+09 8.98 16.7
28.2 1.07E+10 8.11 14.88
45.5 9.47E+09 9.14 16.18  
 
Average values (73 °C – 30 °C) 
 
Flow rate  Nucleation Standard Median   Standard Mean Standard
(mL/min) rate (m-3s-1) deviation (m-3s-1) (µm) deviation (µm)  (µm) deviation (µm)







Experimental values (73 °C – 40 °C) 
 
Flow rate (mL/min) Nucleation rate (m-3s-1) Median (µm) Mean (µm)
11.9 9.51E+08 12.49 20.68
28.2 8.23E+08 11.71 19.51
28.2 1.02E+09 10.62 19.37
45.5 9.86E+08 10.97 18.81  
 
Average values (73 °C – 40 °C) 
 
Flow rate  Nucleation Standard Median   Standard Mean Standard
(mL/min) rate (m-3s-1) deviation (m-3s-1) (µm) deviation (µm)  (µm) deviation (µm)
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